STOCK TITAN

XMax (NASDAQ: NVFY) Q1 2026 net income boosted by fund gains and equity raise

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
10-Q

Rhea-AI Filing Summary

XMax Inc. reported a small profit for the three months ended March 31, 2026, mainly from investment gains rather than its core furniture business. Net sales were $1.78 million, down from $2.64 million a year earlier, and operations generated a loss of $0.53 million. A net other income contribution of $0.73 million, including an unrealized gain of about $0.79 million on its investment funds, lifted net income to $191,514 versus a prior-year net loss of $338,871.

Cash and cash equivalents increased to $9.9 million, helped by $12.20 million of common stock issued to investors, offset by $8.35 million of new investments in Preamble-managed funds that hold interests in SpaceX and xAI, and a new $5.3 million loan to a third party at 6% interest. Total assets rose to $47.14 million, with investment in fund at $26.95 million. Total liabilities declined to $6.79 million, including $5.12 million of convertible notes, and stockholders’ equity increased to $40.35 million. Common shares outstanding grew to 53.53 million at March 31, 2026, and 63.60 million as of May 14, 2026.

Positive

  • None.

Negative

  • Core operations weakened: Q1 2026 net sales fell to $1.78 million from $2.64 million and the operating loss widened to $0.53 million, indicating continued pressure on the underlying furniture business.
  • Reliance on investment gains and dilution: Net income of $191,514 depended on an unrealized gain of about $0.79 million on investment funds, while equity financing of $12.20 million and share count growth to 63.60 million increased dilution risk.
Net sales $1,781,721 Three months ended March 31, 2026
Net sales prior year $2,635,718 Three months ended March 31, 2025
Net income (loss) $191,514 Three months ended March 31, 2026; vs $(338,871) in 2025
Cash and cash equivalents $9,911,255 Balance at March 31, 2026
Investment in fund $26,947,613 Balance at March 31, 2026, level 3 fair value
Unrealized gain on investments $794,212 Other income in Q1 2026
Loan to third party $5,300,000 Principal at 6% interest, funded January 28, 2026
Common shares outstanding 63,602,326 shares Outstanding as of May 14, 2026
One Big Beautiful Bill Act financial
"On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the U.S."
A "one big beautiful bill act" is a single, large piece of legislation that bundles many policy changes and measures into one package instead of passing them separately. For investors, it matters because such omnibus bills can swiftly change tax rules, spending levels, industry regulations or subsidies all at once—like a single shopping cart that suddenly adds many items to a household budget—creating broad, rapid shifts in company costs, revenues and market expectations.
current expected credit losses (CECL) financial
"the Company changed the impairment model to utilize a forward-looking current expected credit losses (CECL) model"
Current Expected Credit Losses (CECL) is an accounting standard that requires lenders and companies with loans or receivables to estimate and record the lifetime expected losses up front, rather than waiting until a loss is probable. Investors care because CECL changes reported profits and the amount of reserves a firm must hold — like a household setting aside a larger rainy‑day fund based on forecasted storms — which affects capital, dividend capacity and the perceived financial strength of a company.
global intangible low-taxed income financial
"created new taxes on certain foreign-sourced earnings such as global intangible low-taxed income (“GILTI”) under IRC Section 951A"
right-of-use assets financial
"Right-of-use assets, net | $ 424,203 | | $ 594,801"
Right-of-use assets are the rights a company gains to use a physical space or equipment under a lease agreement. They are recorded as assets on the company's balance sheet, reflecting the value of future benefits from the leased item. For investors, these assets provide a clearer picture of a company's obligations and resources related to leasing arrangements, helping to assess its financial health and operational commitments.
Level 3 the fair-value hierarchy financial
"are classified as investment in fund and as level 3 the fair-value hierarchy"
false --12-31 Q1 0001473334 Yes Yes 0001473334 2026-01-01 2026-03-31 0001473334 2026-05-14 0001473334 2026-03-31 0001473334 2025-12-31 0001473334 2025-01-01 2025-03-31 0001473334 us-gaap:CommonStockMember 2025-12-31 0001473334 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001473334 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-12-31 0001473334 us-gaap:RetainedEarningsMember 2025-12-31 0001473334 us-gaap:CommonStockMember 2024-12-31 0001473334 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001473334 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-12-31 0001473334 us-gaap:RetainedEarningsMember 2024-12-31 0001473334 2024-12-31 0001473334 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001473334 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001473334 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-01-01 2026-03-31 0001473334 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001473334 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001473334 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001473334 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-01-01 2025-03-31 0001473334 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001473334 us-gaap:CommonStockMember 2026-03-31 0001473334 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001473334 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001473334 us-gaap:RetainedEarningsMember 2026-03-31 0001473334 us-gaap:CommonStockMember 2025-03-31 0001473334 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001473334 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001473334 us-gaap:RetainedEarningsMember 2025-03-31 0001473334 2025-03-31 0001473334 XWIN:NovaLivingMSDNBHDMember 2019-12-11 2019-12-12 0001473334 XWIN:FormalAgreementMember 2020-01-06 2020-01-07 0001473334 XWIN:NovaHKMember 2020-11-04 2020-11-05 0001473334 2023-05-21 2023-05-22 0001473334 2023-05-22 0001473334 2023-09-05 0001473334 2023-09-04 0001473334 srt:BoardOfDirectorsChairmanMember 2025-11-03 0001473334 srt:BoardOfDirectorsChairmanMember 2025-11-02 0001473334 XWIN:ComputerSoftwareMember 2026-03-31 0001473334 2025-01-01 2025-12-31 0001473334 XWIN:PreambleCapitalLLCMember 2026-03-31 0001473334 XWIN:PreambleCapitalLLCMember 2025-12-31 0001473334 XWIN:PreambleCapitalLLCMember 2026-01-01 2026-03-31 0001473334 us-gaap:SegmentContinuingOperationsMember 2026-01-01 2026-03-31 0001473334 us-gaap:SegmentContinuingOperationsMember 2025-01-01 2025-03-31 0001473334 2024-01-01 2024-03-31 0001473334 us-gaap:RestrictedStockMember 2026-01-01 2026-03-31 0001473334 us-gaap:RestrictedStockMember 2025-01-01 2025-03-31 0001473334 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001473334 us-gaap:WarrantMember 2025-01-01 2025-03-31 0001473334 us-gaap:SalesRevenueNetMember XWIN:OneCustomerMember us-gaap:CustomerConcentrationRiskMember us-gaap:SegmentContinuingOperationsMember 2026-01-01 2026-03-31 0001473334 us-gaap:SalesRevenueNetMember XWIN:OneCustomerMember us-gaap:CustomerConcentrationRiskMember us-gaap:SegmentContinuingOperationsMember 2025-01-01 2025-03-31 0001473334 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember XWIN:OneCustomerMember 2025-01-01 2025-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:MajorVendorOneMember us-gaap:SegmentContinuingOperationsMember 2026-01-01 2026-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:MajorVendorOneMember us-gaap:SegmentContinuingOperationsMember 2025-01-01 2025-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2026-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember 2025-03-31 0001473334 srt:MinimumMember us-gaap:ComputerEquipmentMember 2026-03-31 0001473334 srt:MaximumMember us-gaap:ComputerEquipmentMember 2026-03-31 0001473334 srt:MinimumMember XWIN:DecorationAndRenovationMember 2026-03-31 0001473334 srt:MaximumMember XWIN:DecorationAndRenovationMember 2026-03-31 0001473334 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember XWIN:CustomerAMember 2026-01-01 2026-03-31 0001473334 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember XWIN:CustomerAMember 2026-01-01 2026-03-31 0001473334 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember XWIN:CustomerAMember 2025-01-01 2025-03-31 0001473334 us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember XWIN:CustomerAMember 2025-01-01 2025-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:SupplierAMember 2026-01-01 2026-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:SupplierAMember 2026-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:SupplierBMember 2026-01-01 2026-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:SupplierBMember 2026-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:SupplierCMember 2026-01-01 2026-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:SupplierCMember 2026-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:SupplierDMember 2026-01-01 2026-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:SupplierDMember 2026-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:SupplierAMember 2025-01-01 2025-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:SupplierAMember 2025-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:SupplierBMember 2025-01-01 2025-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:SupplierBMember 2025-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:SupplierCMember 2025-01-01 2025-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:SupplierCMember 2025-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:SupplierDMember 2025-01-01 2025-03-31 0001473334 us-gaap:CostOfGoodsTotalMember us-gaap:SupplierConcentrationRiskMember XWIN:SupplierDMember 2025-03-31 0001473334 XWIN:MYRMember 2025-12-31 0001473334 XWIN:USDollarsMember 2025-12-31 0001473334 XWIN:MYRMember 2025-01-01 2025-03-31 0001473334 XWIN:USDollarsMember 2025-01-01 2025-03-31 0001473334 us-gaap:ComputerEquipmentMember 2026-03-31 0001473334 us-gaap:ComputerEquipmentMember 2025-12-31 0001473334 XWIN:DecorationAndRenovationMember 2026-03-31 0001473334 XWIN:DecorationAndRenovationMember 2025-12-31 0001473334 2025-10-01 2025-10-01 0001473334 XWIN:SubscriptionAgreementMember XWIN:NovaFurnitureLimitedMember 2025-09-25 0001473334 XWIN:SubscriptionAgreementMember 2025-09-25 0001473334 XWIN:SubscriptionAgreementMember XWIN:SpaceExplorationTechnologiesCorpMember 2025-09-25 0001473334 XWIN:SubscriptionAgreementMember XWIN:SpaceExplorationTechnologiesCorpMember 2025-09-25 2025-09-25 0001473334 XWIN:SubscriptionAgreementMember XWIN:SpaceExplorationTechnologiesCorpMember us-gaap:CommonClassAMember 2025-09-25 2025-09-25 0001473334 XWIN:SubscriptionAgreementMember XWIN:SpaceExplorationTechnologiesCorpMember us-gaap:CommonClassCMember 2025-09-25 2025-09-25 0001473334 XWIN:SubscriptionAgreementMember XWIN:SpaceExplorationTechnologiesCorpMember 2025-09-26 2025-09-26 0001473334 XWIN:SubscriptionAgreementMember XWIN:SpaceExplorationTechnologiesCorpMember us-gaap:CommonClassAMember 2025-09-26 2025-09-26 0001473334 XWIN:SubscriptionAgreementMember XWIN:SpaceExplorationTechnologiesCorpMember us-gaap:CommonClassCMember 2025-09-26 2025-09-26 0001473334 XWIN:SubscriptionAgreementMember XWIN:SpaceExplorationTechnologiesCorpMember 2025-09-26 0001473334 XWIN:SubscriptionAgreementMember 2025-09-26 2025-09-26 0001473334 XWIN:SubscriptionAgreementMember XWIN:XmaxAlphaHoldingsLtdMember 2025-10-15 0001473334 XWIN:SubscriptionAgreementMember XWIN:SpaceExplorationTechnologiesCorpMember 2025-10-16 0001473334 XWIN:SubscriptionAgreementMember XWIN:XmaxBetaHoldingsLtdMember 2025-12-02 0001473334 XWIN:SubscriptionAgreementMember XWIN:PreambleXCapitalMember XWIN:SpecialPurposeVehicleMember 2025-12-02 2025-12-02 0001473334 XWIN:SubscriptionAgreementMember XWIN:XmaxBetaHoldingsLtdMember XWIN:SpecialPurposeVehicleMember 2025-12-02 0001473334 XWIN:SubscriptionAgreementMember XWIN:XAIHoldingsCorpMember XWIN:SpecialPurposeVehicleMember us-gaap:SeriesBPreferredStockMember 2025-12-02 2025-12-02 0001473334 XWIN:SubscriptionAgreementMember XWIN:XAIHoldingsCorpMember 2025-12-08 0001473334 XWIN:SubscriptionAgreementMember XWIN:PreambleXCapitalLLCMember 2025-12-16 0001473334 XWIN:SubscriptionAgreementMember 2025-12-17 0001473334 XWIN:SubscriptionAgreementMember XWIN:XAIHoldingsCorpMember 2025-12-18 0001473334 XWIN:SubscriptionAgreementMember XWIN:PreambleXCapitalLLCMember 2026-02-04 0001473334 XWIN:SubscriptionAgreementMember 2026-02-04 0001473334 XWIN:SubscriptionAgreementMember XWIN:PreambleXCapitalMember XWIN:SpecialPurposeVehicleMember 2026-02-04 2026-02-04 0001473334 XWIN:JoycheerTradeLimitedMember XWIN:LoanAgreementMember 2026-01-28 0001473334 2023-09-12 2023-09-12 0001473334 2024-01-01 2024-12-31 0001473334 2025-10-31 2025-10-31 0001473334 XWIN:SBALoanMember 2020-06-19 2020-06-19 0001473334 XWIN:SBALoanMember 2020-06-19 0001473334 XWIN:SBALoanMember 2026-01-01 2026-03-31 0001473334 XWIN:SBALoanMember 2025-01-01 2025-03-31 0001473334 2024-11-14 0001473334 2024-11-14 2024-11-14 0001473334 XWIN:ConvertiblePromissoryNotePurchaseAgreementMember XWIN:BilliongoldHoldingLimitedMember 2025-11-18 2025-11-18 0001473334 XWIN:ConvertiblePromissoryNotePurchaseAgreementMember XWIN:BilliongoldHoldingLimitedMember 2025-11-18 0001473334 XWIN:ConvertiblePromissoryNotePurchaseAgreementMember 2026-01-01 2026-03-31 0001473334 XWIN:DiamondBarMember 2025-04-01 0001473334 XWIN:DiamondBarMember 2025-04-01 2025-04-01 0001473334 XWIN:DiamondBarMember 2026-01-01 2026-03-31 0001473334 XWIN:DiamondBarMember 2025-01-01 2025-03-31 0001473334 XWIN:SalesRepresentativeAgreementMember 2018-01-03 2018-01-04 0001473334 XWIN:SalesRepresentativeAgreementMember 2020-01-03 2020-01-04 0001473334 XWIN:SalesRepresentativeAgreementMember 2026-01-01 2026-03-31 0001473334 XWIN:SalesRepresentativeAgreementMember 2025-01-01 2025-03-31 0001473334 XWIN:PromissoryLoanMember 2024-02-29 2024-02-29 0001473334 XWIN:PromissoryLoanMember 2024-02-29 0001473334 XWIN:PromissoryLoanMember 2025-01-01 2025-03-31 0001473334 XWIN:PromissoryLoanMember 2024-04-11 2024-04-11 0001473334 XWIN:PromissoryLoanMember 2024-04-11 0001473334 XWIN:PromissoryLoanOneMember 2026-01-01 2026-03-31 0001473334 XWIN:PromissoryLoanOneMember 2025-01-01 2025-03-31 0001473334 XWIN:PromissoryLoanMember 2025-04-11 2025-04-11 0001473334 XWIN:PromissoryLoanMember 2025-04-11 0001473334 XWIN:TwoThousandTwentyOneEquityIncentivePlanMember 2021-04-12 0001473334 XWIN:TwoThousandTwentyOneEquityIncentivePlanMember 2021-06-16 0001473334 XWIN:TwoThousandTwentyThreeEquityIncentivePlanMember 2023-06-28 0001473334 XWIN:TwoThousandTwentyThreeEquityIncentivePlanMember 2023-12-15 0001473334 XWIN:TwentyTwentyFourEquityIncentivePlanMember 2024-04-19 0001473334 2024-04-18 2024-04-18 0001473334 2024-10-11 0001473334 us-gaap:CommonStockMember 2024-10-11 2024-10-11 0001473334 us-gaap:InvestorMember XWIN:SecuritiesPurchaseAgreementMember 2024-05-16 2024-05-16 0001473334 us-gaap:InvestorMember XWIN:SecuritiesPurchaseAgreementMember 2024-05-16 0001473334 us-gaap:InvestorMember XWIN:SecuritiesPurchaseAgreementMember 2024-07-30 2024-07-30 0001473334 us-gaap:InvestorMember XWIN:SecuritiesPurchaseAgreementMember 2024-07-30 0001473334 XWIN:NovaSamoaMember XWIN:IconicTechMember 2024-10-11 2024-10-11 0001473334 XWIN:NovaSamoaMember XWIN:OnefullTechnologiesMember 2024-10-11 2024-10-11 0001473334 XWIN:NovaSamoaMember XWIN:SkyvipMember 2024-10-11 2024-10-11 0001473334 XWIN:NovaSamoaMember XWIN:UnitedPolesMember 2024-10-11 2024-10-11 0001473334 XWIN:NovaSamoaMember XWIN:TeclutionsMember 2024-10-11 2024-10-11 0001473334 XWIN:NovaSamoaMember 2024-10-11 2024-10-11 0001473334 XWIN:NovaSamoaMember 2024-10-11 0001473334 XWIN:SecuritiesPurchaseAgreementMember 2024-10-25 2024-10-25 0001473334 XWIN:SecuritiesPurchaseAgreementMember 2024-10-25 0001473334 XWIN:SecuritiesPurchaseAgreementMember 2025-01-06 2025-01-06 0001473334 XWIN:SecuritiesPurchaseAgreementMember 2025-01-06 0001473334 XWIN:SecuritiesPurchaseAgreementMember 2025-02-10 2025-02-10 0001473334 XWIN:SecuritiesPurchaseAgreementMember 2025-02-10 0001473334 XWIN:SecuritiesPurchaseAgreementMember 2025-02-20 2025-02-20 0001473334 XWIN:SecuritiesPurchaseAgreementMember 2025-02-20 0001473334 XWIN:NovaSamoaMember XWIN:FlyguyResourcesMember 2025-02-26 2025-02-26 0001473334 XWIN:NovaSamoaMember XWIN:TwentyNineBusinessMember 2025-02-26 2025-02-26 0001473334 XWIN:NovaSamoaMember XWIN:ChialingOrderPriceMember 2025-02-26 2025-02-26 0001473334 XWIN:NovaSamoaMember XWIN:MacroOrderPriceMember 2025-02-26 2025-02-26 0001473334 us-gaap:CommonStockMember 2025-02-26 2025-02-26 0001473334 us-gaap:CommonStockMember 2025-02-26 0001473334 XWIN:SecuritiesPurchaseAgreementMember us-gaap:PrivatePlacementMember 2025-03-13 2025-03-13 0001473334 XWIN:SecuritiesPurchaseAgreementMember us-gaap:PrivatePlacementMember 2025-03-13 0001473334 XWIN:SecuritiesPurchaseAgreementMember us-gaap:IPOMember 2025-09-04 2025-09-04 0001473334 XWIN:SecuritiesPurchaseAgreementMember us-gaap:IPOMember 2025-09-04 0001473334 XWIN:SecuritiesPurchaseAgreementMember us-gaap:WarrantMember 2025-09-04 2025-09-04 0001473334 XWIN:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2025-09-04 2025-09-04 0001473334 XWIN:SecuritiesPurchaseAgreementMember us-gaap:WarrantMember 2025-09-04 0001473334 XWIN:SecuritiesPurchaseAgreementMember 2025-09-04 0001473334 XWIN:SecuritiesPurchaseAgreementMember 2025-09-04 2025-09-04 0001473334 XWIN:PlacementAgentMember 2025-09-04 2025-09-04 0001473334 us-gaap:WarrantMember 2025-09-04 2025-09-04 0001473334 us-gaap:CommonStockMember XWIN:SecuritiesPurchaseAgreementMember 2025-10-13 2025-10-13 0001473334 XWIN:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2025-10-13 0001473334 us-gaap:CommonStockMember XWIN:SecuritiesPurchaseAgreementMember 2025-12-19 2025-12-19 0001473334 XWIN:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2025-12-19 0001473334 us-gaap:CommonStockMember XWIN:SecuritiesPurchaseAgreementMember 2026-03-09 2026-03-09 0001473334 XWIN:SecuritiesPurchaseAgreementMember us-gaap:CommonStockMember 2026-03-09 0001473334 us-gaap:PrivatePlacementMember 2026-03-30 2026-03-30 0001473334 us-gaap:PrivatePlacementMember 2026-03-30 0001473334 us-gaap:PrivatePlacementMember 2021-07-23 2021-07-23 0001473334 us-gaap:PrivatePlacementMember 2021-07-23 0001473334 XWIN:PlacementAgentMember us-gaap:WarrantMember 2021-07-23 0001473334 us-gaap:PrivatePlacementMember us-gaap:WarrantMember 2026-01-01 2026-03-31 0001473334 XWIN:ConsultingAgreementOneMember 2024-03-01 2024-03-01 0001473334 XWIN:ConsultingAgreementOneMember 2024-06-01 2024-06-01 0001473334 XWIN:ConsultingAgreementOneMember 2024-09-01 2024-09-01 0001473334 XWIN:ConsultingAgreementOneMember 2024-12-01 2024-12-01 0001473334 XWIN:ConsultingAgreementOneMember 2024-03-01 0001473334 XWIN:ConsultingAgreementOneMember 2026-01-01 2026-03-31 0001473334 XWIN:ConsultingAgreementOneMember 2025-01-01 2025-03-31 0001473334 XWIN:ConsultingAgreementTwoMember 2024-09-03 2024-09-03 0001473334 XWIN:ConsultingAgreementTwoMember 2024-12-03 2024-12-03 0001473334 XWIN:ConsultingAgreementTwoMember 2024-03-03 2024-03-03 0001473334 XWIN:ConsultingAgreementTwoMember 2024-06-03 2024-06-03 0001473334 XWIN:ConsultingAgreementTwoMember 2024-09-03 0001473334 XWIN:ConsultingAgreementTwoMember 2026-01-01 2026-03-31 0001473334 XWIN:ConsultingAgreementTwoMember 2025-01-01 2025-03-31 0001473334 XWIN:ConsultingAgreementThreeMember 2024-11-07 2024-11-07 0001473334 XWIN:ConsultingAgreementThreeMember 2025-02-15 2025-02-15 0001473334 XWIN:ConsultingAgreementThreeMember 2025-05-15 2025-05-15 0001473334 XWIN:ConsultingAgreementThreeMember 2025-08-15 2025-08-15 0001473334 XWIN:ConsultingAgreementThreeMember 2025-11-15 2025-11-15 0001473334 XWIN:ConsultingAgreementThreeMember 2024-11-16 2024-11-16 0001473334 XWIN:ConsultingAgreementThreeMember 2024-11-16 0001473334 XWIN:ConsultingAgreementThreeMember 2026-01-01 2026-03-31 0001473334 XWIN:ConsultingAgreementThreeMember 2025-01-01 2025-03-31 0001473334 XWIN:EmployementAgreementThreeMember XWIN:TwoThousandTwentyThreeOmnibusEquityPlanMember 2024-11-07 2024-11-07 0001473334 XWIN:EmployementAgreementThreeMember XWIN:TwoThousandTwentyThreeOmnibusEquityPlanMember 2024-11-07 0001473334 XWIN:EmployementAgreementThreeMember XWIN:TwoThousandTwentyThreeOmnibusEquityPlanMember 2025-03-31 2025-03-31 0001473334 XWIN:EmployementAgreementThreeMember XWIN:TwoThousandTwentyThreeOmnibusEquityPlanMember 2025-06-30 2025-06-30 0001473334 XWIN:EmployementAgreementThreeMember XWIN:TwoThousandTwentyThreeOmnibusEquityPlanMember 2025-09-30 2025-09-30 0001473334 XWIN:EmployementAgreementThreeMember XWIN:TwoThousandTwentyThreeOmnibusEquityPlanMember 2026-01-01 2026-03-31 0001473334 XWIN:EmployementAgreementThreeMember XWIN:TwoThousandTwentyThreeOmnibusEquityPlanMember 2025-01-01 2025-03-31 0001473334 us-gaap:WarrantMember 2025-12-31 0001473334 us-gaap:WarrantMember 2025-01-01 2025-12-31 0001473334 us-gaap:WarrantMember 2026-01-01 2026-03-31 0001473334 us-gaap:WarrantMember 2026-03-31 0001473334 srt:NorthAmericaMember 2026-01-01 2026-03-31 0001473334 srt:NorthAmericaMember 2025-01-01 2025-03-31 0001473334 country:HK 2026-01-01 2026-03-31 0001473334 country:HK 2025-01-01 2025-03-31 0001473334 XWIN:OtherCountriesMember 2026-01-01 2026-03-31 0001473334 XWIN:OtherCountriesMember 2025-01-01 2025-03-31 0001473334 srt:NorthAmericaMember 2026-03-31 0001473334 srt:NorthAmericaMember 2025-03-31 0001473334 srt:AsiaMember 2026-03-31 0001473334 srt:AsiaMember 2025-03-31 0001473334 XWIN:LeaseAgreementMember 2013-06-17 0001473334 XWIN:LeaseAgreementMember 2013-06-17 2013-06-17 0001473334 XWIN:LeaseAgreementMember 2018-04-23 0001473334 XWIN:LeaseAgreementMember 2018-04-23 2018-04-23 0001473334 XWIN:LeaseAgreementMember 2021-10-15 0001473334 XWIN:LeaseAgreementMember 2021-10-15 2021-10-15 0001473334 XWIN:SubLeaseAgreementMember 2019-07-15 0001473334 XWIN:SubLeaseAgreementMember 2019-07-15 2019-07-15 0001473334 XWIN:SubLeaseAgreementMember 2020-07-31 2020-08-01 0001473334 XWIN:SubLeaseAgreementMember 2021-07-15 0001473334 XWIN:LeaseAgreementMember 2019-10-29 0001473334 XWIN:LeaseAgreementMember 2019-10-29 2019-10-29 0001473334 XWIN:LeaseAgreementMember 2021-11-26 0001473334 XWIN:LeaseAgreementMember 2022-10-04 0001473334 XWIN:LeaseAgreementMember 2022-10-04 2022-10-04 0001473334 XWIN:SubLeaseAgreementMember 2020-08-20 0001473334 XWIN:SubLeaseAgreementMember 2020-08-20 2020-08-20 0001473334 XWIN:SubLeaseAgreementMember 2022-07-29 0001473334 XWIN:SubLeaseAgreementMember 2022-07-29 2022-07-29 0001473334 XWIN:AutoLeaseAgreementMember 2022-08-31 0001473334 XWIN:AutoLeaseAgreementMember 2022-08-31 2022-08-31 0001473334 XWIN:AutoLeaseAgreementMember 2024-11-08 0001473334 XWIN:AutoLeaseAgreementMember 2024-11-08 2024-11-08 0001473334 XWIN:LeaseAgreementMember 2024-12-09 0001473334 XWIN:LeaseAgreementMember 2024-12-09 2024-12-09 0001473334 XWIN:SubLeaseAgreementMember 2025-07-01 0001473334 2025-07-01 2025-07-01 0001473334 XWIN:SubLeaseAgreementMember 2025-07-31 2025-07-31 0001473334 XWIN:SubLeaseAgreementMember 2025-08-31 2025-08-31 0001473334 XWIN:SubLeaseAgreementMember 2025-09-30 2025-09-30 0001473334 country:US 2026-03-31 0001473334 XWIN:ServiceAgreementMember us-gaap:SubsequentEventMember 2026-04-01 2026-04-01 0001473334 us-gaap:PrivatePlacementMember us-gaap:SubsequentEventMember XWIN:SecuritiesPurchaseAgreementMember 2026-04-13 2026-04-13 0001473334 us-gaap:PrivatePlacementMember us-gaap:SubsequentEventMember XWIN:SecuritiesPurchaseAgreementMember 2026-04-13 0001473334 XWIN:XmaxBetaHoldingsLtdMember us-gaap:SubsequentEventMember 2026-04-15 0001473334 XWIN:PreambleXCapitalLLCMember us-gaap:SubsequentEventMember 2026-04-15 0001473334 XWIN:SubscriptionAgreementMember XWIN:PreambleCapitalLLCMember us-gaap:SubsequentEventMember 2026-04-17 0001473334 XWIN:SubscriptionAgreementMember XWIN:PreambleCapitalLLCMember us-gaap:SubsequentEventMember 2026-04-17 2026-04-17 0001473334 us-gaap:SubsequentEventMember 2026-04-22 2026-04-22 0001473334 us-gaap:PrivatePlacementMember us-gaap:SubsequentEventMember XWIN:SecuritiesPurchaseAgreementMember 2026-04-24 2026-04-24 0001473334 us-gaap:PrivatePlacementMember us-gaap:SubsequentEventMember XWIN:SecuritiesPurchaseAgreementMember 2026-04-24 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure XWIN:Segment iso4217:MYR

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 10-Q

 

 

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the quarterly period ended March 31, 2026
   
OR  
   
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission file number: 001-36259

 

XMAX INC.

(Exact name of registrant as specified in its charter)

 

Nevada   90-0746568

(State or other jurisdiction

of incorporation or organization)

 

(IRS Employer

Identification No.)

 

6565 E. Washington Blvd. Commerce, CA   90040
(Address of principal executive offices)   (Zip Code)

 

(323) 888-9999

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.001 per share   XWIN   Nasdaq Stock Market

 

Indicate by checkmark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the last 90 days.

 

YES ☒ NO ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

 

YES ☒ NO ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” accelerated filer” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:

 

Large accelerated filer ☐   Accelerated filer ☐
Non-accelerated filer   Smaller reporting company
Emerging growth company    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

 

YES ☐ NO

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: 63,602,326 shares of common stock outstanding as of May 14, 2026.

 

 

 

 

 

 

XMax Inc.

 

Table of Contents

 

    Page
PART I. FINANCIAL INFORMATION  
     
Item 1. Financial Statements 1
  Condensed Consolidated Balance Sheets as of March 31, 2026 (unaudited) and December 31, 2025 1
  Condensed Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) for the three months ended March 31, 2026 and 2025 (unaudited) 3
  Condensed Consolidated Statements of Stockholders’ Equity for the three months ended March 31, 2026 and 2025 (unaudited) 4
  Condensed Consolidated Statements of Cash Flows for the three months ended March 31, 2026 and 2025 (unaudited) 5
  Notes to Condensed Consolidated Financial Statements for the three months ended March 31, 2026 and 2025 (unaudited) 6
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 35
Item 3. Quantitative and Qualitative Disclosures about Market Risk 50
Item 4. Controls and Procedures 50
     
PART II. OTHER INFORMATION  
     
Item 1. Legal Proceedings 51
Item 1A. Risk Factors 51
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 51
Item 5. Other Information 51
Item 6. Exhibits 51
     
  Signatures 52

 

i

Table of Contents

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

XMAX INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

AS OF MARCH 31, 2026 AND DECEMBER 31, 2025

(Stated in U.S. Dollars, except for Number of Shares)

 

 

   March 31, 2026   December 31, 2025 
   Unaudited   Audited 
Assets          
           
Current Assets          
Cash and cash equivalents  $9,911,255   $6,708,340 
Accounts receivable, net   2,457,238    2,445,245 
Advance to suppliers   225,604    313,924 
Inventories   1,656,675    2,163,437 
Loan to third party   5,354,888     
Prepaid expenses   58,492    144,274 
Other receivables   40,925    7,478 
           
Total Current Assets   19,705,077    11,782,698 
           
Noncurrent Assets          
Plant, property and equipment, net   19,854    21,942 
Right-of-use assets, net   424,203    594,801 
Investment in fund   26,947,613    23,104,628 
Lease deposit   43,260    43,260 
           
Total Noncurrent Assets   27,434,930    23,764,631 
           
Total Assets  $47,140,007   $35,547,329 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

1

Table of Contents

 

XMAX INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (CONT’D)

AS OF MARCH 31, 2026 AND DECEMBER 31, 2025

(Stated in U.S. Dollars, except for Number of Shares)

 

 

   March 31, 2026   December 31, 2025 
   Unaudited   Audited 
Liabilities and Stockholders’ Equity          
           
Current Liabilities          
Accounts payable  $128,574   $327,134 
Operating lease liabilities, current   415,678    591,350 
Finance lease liabilities - current   20,858    20,574 
Contract liabilities   89,147    58,786 
Loan from shareholders   406,135    398,014 
Accrued liabilities and other payables   456,698    943,312 
Other loan   3,605    3,572 
Security deposit       50,000 
           
Total Current Liabilities   1,520,695    2,392,742 
           
Noncurrent Liabilities          
Other loan   136,186    137,117 
Finance lease liabilities - non-current   14,553    19,876 
Convertible notes   5,117,616    5,038,026 
           
Total Noncurrent Liabilities   5,268,355    5,195,019 
           
Total Liabilities   6,789,050    7,587,761 
           
Contingencies and Commitments   -    - 
           
Stockholders’ Equity          
Common stock, $0.001 par value; 5,000,000,000 shares authorized, 53,531,228 and 41,885,728 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively   53,531    41,886 
Additional paid-in capital   93,011,758    80,823,528 
Accumulated other comprehensive income   504,247    504,247 
Accumulated deficits   (53,218,579)   (53,410,093)
           
Total Stockholders’ Equity   40,350,957    27,959,568 
           
Total Liabilities and Stockholders’ Equity  $47,140,007   $35,547,329 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

2

Table of Contents

 

XMAX INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF INCOME/ (LOSS) AND COMPREHENSIVE INCOME/ (LOSS)

FOR THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025 (UNAUDITED)

(Stated in U.S. Dollars, except for Number of Shares)

 

 

       
   Three Months Ended March 31, 
   2026   2025 
         
Net Sales  $1,781,721   $2,635,718 
           
Cost of Sales   899,252    1,431,484 
           
Gross Profit   882,469    1,204,234 
           
Operating Expenses          
Selling expenses   369,425    327,596 
General and administrative expenses   1,047,897    1,069,608 
Research and development       390 
           
Total Operating Expenses   1,417,322    1,397,594 
           
Loss From Operations   (534,853)   (193,360)
           
Other Income (Expenses)          
Non-operating income   4,909    76,893 
Loss on impairment of goodwill       (218,606)
Unrealized gain   794,212     
Foreign exchange transaction loss       (3,987)
Interest expense, net   (35,068)   (7,762)
Financial expense   (37,686)   (54,309)
           
Total Other Income (Expenses), Net   726,367    (207,771)
           
Income (Loss) Before Income Taxes   191,514    (401,131)
           
Income Tax Benefit       62,260 
           
Net Income (Loss)   191,514    (338,871)
           
Other Comprehensive Loss          
Foreign currency translation       (2,975)
           
Net Income (Loss) and Comprehensive Income (Loss)   191,514    (341,846)
           
Weighted average shares outstanding - Basic and Diluted   44,829,706    9,780,576 
           
Net income (loss) per share of common stock          
Basic and Diluted  $0.00   $(0.03)

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

3

Table of Contents

 

XMAX INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

FOR THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025 (UNAUDITED)

(Stated in U.S. Dollars, except for Number of Shares)

 

 

Three Months Ended March 31, 2026

 

   Shares                
               Accumulated         
           Additional   Other       Total 
   Common stock   Paid-in   Comprehensive   Accumulated   Stockholders’ 
   Shares   Amount   Capital   Income   Deficits   Equity 
                         
Balance at beginning of period   41,885,728   $41,886   $80,823,528   $504,247   $(53,410,093)  $27,959,568 
                               
Stock issued to investors   11,645,500    11,645    12,188,230    -    -    12,199,875 
                               
Net income   -    -    -    -    191,514    191,514 
Balance at end of period   53,531,228   $53,531   $93,011,758   $504,247   $(53,218,579)  $40,350,957 

 

Three Months Ended March 31, 2025

 

               Accumulated         
           Additional   Other       Total 
   Common stock   Paid-in   Comprehensive   Accumulated   Stockholders’ 
   Shares   Amount   Capital   Income   Deficits   Equity 
                         
Balance at beginning of period   7,301,206   $7,301   $52,585,582   $522,146   $(49,991,515)  $3,123,514 
                               
Stock issued to employees   1,500    2    1,469    -    -    1,471 
                               
Stock issued to consultants   62,500    63    83,187    -    -    83,250 
                               
Stock issued to creditor   434,000    434    216,566    -    -    217,000 
                               
Stock issued to suppliers   4,909,616    4,909    3,186,341    -    -    3,191,250 
                               
Stock issued to an investor   1,000,000    1,000    499,000    -    -    500,000 
                               
Foreign currency translation loss   -    -    -    (2,975)   -    (2,975)
                               
Net loss   -    -    -    -    (338,871)   (338,871)
Balance at end of period   13,708,822   $13,709   $56,572,145   $519,171   $(50,330,386)  $6,774,639 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

4

Table of Contents

 

 XMAX, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

FOR THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025

 

 

       
   Three Months Ended March 31, 
   2026   2025 
     
Cash Flows From Operating Activities          
Net income (loss)  $191,514   $(338,871)
           
Adjustments to reconcile net income to net cash (used in) provided by operating activities:          
Depreciation and amortization   2,088    15,836 
Plant, property and equipment written off   5,091     
Amortization of operating lease right-of-use assets   160,416    182,246 
Write down of inventories   2,354    3,681 
Stock based compensation expense to employee       1,470 
Stock based compensation expense to non-employee       110,156 
Unrecognized gain   (794,212)    
Loss on impairment of goodwill       218,606 
Allowance credit loss   121    287 
Changes in operating assets and liabilities:          
Accounts receivable   (12,113)   (28,692)
Advance to suppliers   88,320    5,224 
Inventories   504,408    715,364 
Prepaid expenses   85,782     
Other current assets   (83,447)   181,094 
Operating lease liabilities   (170,074)   (186,413)
Accounts payable   (198,560)   (444,130)
Contract liabilities   30,361    (100,343)
Accrued liabilities and other payables   (453,793)   (595,872)
Taxes payable       (62,260)
           
Net Cash Used in Operating Activities   (641,744)   (322,617)
           
Cash Flows From Investing Activities          
Loan to third party   (5,300,000)    
Investment in fund of Preamble Capital LLC   (3,048,773)    
           
Net Cash Used in Investing Activities   (8,348,773)    
           
Cash Flows From Financing Activities          
Repayment to loan from shareholder       (217,000)
Repayment to SBA loan   (898)   (867)
Principal payment of finance lease liabilities   (5,039)    
Interest paid on finance lease liabilities   (506)    
Proceed from issuing common stocks   12,199,875    500,000 
           
Net Cash Provided by Financing Activities   12,193,432    282,133 
           
Effect of Exchange Rate Changes on Cash and Cash Equivalents  $   $25,882 
           
Net Increase (Decrease) in Cash and Cash Equivalents   3,202,915    (14,602)
           
Cash and Cash Equivalents, Beginning of Period   6,708,340    161,902 
           
Cash and Cash Equivalents, Ending of Period  $9,911,255   $147,300 
           
Supplemental Disclosure of Cash Flow Information          
           
Continuing operations:          
Cash paid during period for:          
Income tax payments  $   $ 
Interest expense  $89,971   $7,785 

 

The accompanying notes are an integral part of these condensed consolidated financial statements.

 

5

Table of Contents

 

XMAX INC. AND SUBSIDIARIES

NOTES TO CONDESED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE MONTHS ENDED MARCH 31, 2026 AND 2025

 

Note 1 - Organization and Description of Business

 

Organization and Business

 

XMax Inc. (“XMAX” or the “Company”), formerly known as Nova LifeStyle, Inc. or Stevens Resources, Inc., was incorporated in the State of Nevada on September 9, 2009.

 

The Company is a U.S. holding company with no material assets other than the ownership interests of its subsidiaries through which it markets, designs and sells furniture worldwide: Nova Furniture Limited domiciled in the British Virgin Islands (“Nova Furniture”), Nova Furniture Ltd. domiciled in Samoa (“Nova Samoa”), Diamond Bar Outdoors, Inc. domiciled in California (“Diamond Bar”), i Design Blockchain Technology, Inc. domiciled in California (“i Design”) and Nova Living (M) SDN. BHD. domiciled in Malaysia (“Nova Malaysia”). The Company had three former subsidiaries Bright Swallow International Group Limited domiciled in Hong Kong (“Bright Swallow” or “BSI”) which was sold in January 2020, Nova Furniture Macao Commercial Offshore Limited domiciled in Macao (“Nova Macao”) which was de-registered and liquidated in January 2021 and Nova Living (HK) Group Limited domiciled in Hong Kong (“Nova HK”) which was de-registered and liquidated in February 2023.

 

Nova Macao was organized under the laws of Macao on May 20, 2006, and was a wholly owned subsidiary of Nova Furniture. Nova Macao was a trading company, importing, marketing and selling products designed and manufactured by third-party manufacturers for the international market. Diamond Bar was incorporated in California on June 15, 2000. Diamond Bar markets and sells products manufactured by third-party manufacturers under the Diamond Sofa brand to distributors and retailers principally in the U.S. market.

 

On December 7, 2017, the company incorporated i Design under the laws of the State of California. The purpose of i Design is to build the Company’s own blockchain technology team. This company will focus on the application of blockchain technology in the furniture industry, including encouraging and facilitating interactions among designers and customers, and building a blockchain-powered platform that enables designers to showcase their products, including current and future furniture designs. This company is in the planning stage and has had minimal operations through December 31, 2025.

 

On December 12, 2019, the Company acquired Nova Malaysia at cost of $1.00 which was incorporated in Malaysia on July 26, 2019. The purpose of this acquisition was to market and sell high-end physiotherapeutic jade mats in Malaysia. Nova Malaysia ceased its business operations and started the process of de-registered with Malaysia government in October 2025 and it completed the de-registration and liquidation process during the first quarter of 2026.

 

On January 7, 2020, the Company transferred its entire interest in Bright Swallow to Y-Tone (Worldwide) Limited, an unrelated third party, for cash consideration of $2,500,000, pursuant to a formal agreement entered into on January 7, 2020. The Company received the payment on May 11, 2020.

 

On October 14, 2020, the Macao Trade and Investment Promotion Institute invalidated licenses for offshore companies under an Order of Repeal of Legal Regime of the Offshore Services by Macao Special Administrative Region. Nova Macao then entered into a de-registration process and its business was taken over by Nova HK. Nova Macao completed the de-registration and liquidation process in January 2021.

 

On November 5, 2020, Nova LifeStyle acquired Nova HK at cost of $1,290 which was incorporated in Hong Kong on November 6, 2019. This company had minimal operations other than to take over the business of Nova Macao. On February 15, 2022, the Company transferred its entire assets and business in Nova HK to Nova Malaysia, a subsidiary of the Company. In February 2023, Nova HK completed the process of de-registration and liquidation.

 

On September 24, 2025, the Company incorporate Xmax Capital Ltd. in Samoa (“Xmax Samoa”). On October 3, 2025, Xmax Samoa incorporated Xmax Alpha Holdings Ltd. in Cayman Islands. On October 14, 2025, Xmax Samoa incorporated Xmax Beta Holdings Ltd. and Xmax Delta Holdings Ltd. in Cayman Islands. On October 15, 2025, Xmax Samoa incorporated Xmax Sigma Holdings Ltd. in Cayman Islands. Xmax Samoa is a holding company with no actual business operations. Xmax Delta Holdings Ltd. and Xmax Sigma Holdings Ltd. currently do not have any business operations. On April 1, 2026, the Company incorporated XMax AI Inc. in the State of Nevada.

 

The “Company,” “XMax,” “we,” “us,” and “Nova” collectively refer to XMax Inc., formerly known as Nova LifeStyle, the U.S. parent, and its subsidiaries, Nova Furniture, Nova Samoa, Diamond Bar, i Design, Nova HK, Nova Malaysia, Xmax Capital, Xmax Alpha Holdings Ltd, Xmax Beta Holdings Ltd, Xmax Delta Holdings Ltd and Xmax Sigma Holdings Ltd.

 

6

Table of Contents

 

Note 2 - Summary of Significant Accounting Policies

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding financial reporting. The unaudited condensed consolidated financial statements include the financial statements of the Company and its subsidiaries. All significant inter-company transactions and balances have been eliminated in consolidation.

 

Reverse split

 

On May 22, 2023, the Company filed a Certificate of Change with the Secretary of State of Nevada with an effective date of May 22, 2023, at which time a 1-for-5 reverse stock split of the Company’s authorized shares of common stock, par value $0.001, accompanied by a corresponding decrease in the Company’s issued and outstanding shares of common stock (the “Reverse Stock Split”). All references to shares and per share data have been retroactively restated to reflect such split.

 

Amendments to Articles of Incorporation

 

On September 5, 2023, the Company filed the Certificate of Change (the “Amendment”) with the Secretary of State for the State of Nevada to amend its Articles of Incorporation to increase the amount of authorized shares of its common stock, par value $0.001 per share, from 3,000,000 to 250,000,000. The Amendment was approved by the Company’s Board of Directors (the “Board”) on June 28, 2023 and by the shareholders at a special meeting of the Company’s shareholders held on August 31, 2023. The Amendment does not affect the rights of the Company’s shareholders and was effective immediately upon filing.

 

On November 3, 2025, the Company filed a Certificate of Change (the “Share Increase Amendment”) with the Secretary of State for the State of Nevada to amend its Articles of Incorporation to increase the amount of authorized shares of its common stock, par value $0.001 per share, from 250,000,000 shares to 5,000,000,000 shares. The Share Increase Amendment was approved by the Company’s Board of Directors (the “Board”) on September 15, 2025 and by the shareholders at a special meeting of the Company’s shareholders held on October 31, 2025. The Share Increase Amendment does not affect the rights of the Company’s shareholders and was effective immediately upon filing.

 

On November 3, 2025, the Company filed a Certificate of Amendment (the “Name Change Amendment”) with the Secretary of State for the State of Nevada to amend its Articles of Incorporation to change the Company’s name from “Nova LifeStyle, Inc.” to “XMax Inc.” The Name Change Amendment was approved by the Board on September 15, 2025 and by the shareholders at a special meeting of the Company’s shareholders held on October 31, 2025. The Name Change Amendment was effective immediately upon filing.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, management reviews these estimates and assumptions using the currently available information. Changes in facts and circumstances may cause the Company to revise its estimates. In accordance with ASC 250, the changes in estimates will be recognized in the same period of changes in facts and circumstances. The Company bases its estimates on past experiences and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Estimates are used when accounting for items and matters including, but not limited to, fair value estimation of investment, the allowance for credit loss, valuation of inventories, the valuation of stock-based compensation, income taxes and unrecognized tax benefits, assumptions used in assessing impairment of long-lived assets and goodwill, and loss contingencies. Actual results could differ from those estimates.

 

7

Table of Contents

 

Business Combination

 

For a business combination, the assets acquired, the liabilities assumed and any noncontrolling interest in the acquiree are recognized at the acquisition date and measured at their fair values as of that date. In a business combination achieved in stages, the identifiable assets and liabilities, as well as the noncontrolling interest in the acquiree, are recognized at the full amounts of their fair values. In a bargain purchase in which the total acquisition-date fair value of the identifiable net assets acquired exceeds the fair value of the consideration transferred plus any noncontrolling interest in the acquiree, that excess in earnings is recognized as a gain attributable to the acquirer.

 

Deferred tax liability and assets are recognized for the deferred tax consequences of differences between the tax bases and the recognized values of assets acquired and liabilities assumed in a business combination in accordance with Accounting Standards Codification (“ASC”) Topic 740-10.

 

Goodwill

 

Goodwill is the excess of purchase price and related costs over the value assigned to the net tangible and identifiable intangible assets of businesses acquired. In accordance with ASC Topic 350, “Intangibles-Goodwill and Other,” goodwill is not amortized but is tested for impairment, annually or more frequently when circumstances indicate a possible impairment may exist. Impairment testing is performed at a reporting unit level. An impairment loss generally would be recognized when the carrying amount of the reporting unit exceeds its fair value, with the fair value of the reporting unit determined using discounted cash flow (“DCF”) analysis. A number of significant assumptions and estimates are involved in the application of the DCF analysis to forecast operating cash flows, including the discount rate, the internal rate of return and projections of realizations and costs to produce. Management considers historical experience and all available information at the time the fair values of its reporting units are estimated.

 

ASC Topic 350 also permits an entity to first assess qualitative factors to determine whether it is more likely than not (that is, a likelihood of more than 50 percent) that the fair value of a reporting unit is less than its carrying amount, including goodwill. If it is more likely than not that the fair value of a reporting unit is less than its carrying amount, then the single step goodwill impairment test is required to be performed. Otherwise, no further testing is required. Performing the qualitative assessment involved identifying the relevant drivers of fair value, evaluating the significance of all identified relevant events and circumstances, and weighing the factors to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. The Company completed the required testing of goodwill for impairment as of December 31, 2025, and determined that goodwill was impaired because of the current financial condition of the Company and the Company’s inability to generate future operating income without substantial sales volume increases, which are highly uncertain. Furthermore, the Company anticipates future cash flows indicate that the recoverability of goodwill is not reasonably assured.

 

The goodwill write-down was reflected as an impairment loss, $218,606, in non-operating expenses in the condensed consolidated statement of loss and comprehensive loss for the three months end March 31, 2025.

 

Intangible Assets

 

Intangible assets consist primarily of computer software acquired for internal use. Acquired intangible assets are initially recorded at the acquisition-date fair value. Intangible assets are amortized on a straight-line basis over their estimated useful lives and are carried at cost less accumulated amortization. The estimated useful life of computer software are generally from 5 years.

 

8

Table of Contents

 

Cash and Cash Equivalents

 

Cash and cash equivalents consist of cash on hand, cash at banks that are readily convertible into known amounts of cash, are subject to an insignificant risk of changes in value.

 

Accounts Receivable

 

Since January 1, 2024, the Company adopted Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), using the modified retrospective transition method. ASU 2016-13 replaces the existing incurred loss impairment model with an expected loss methodology, which will result in more timely recognition of credit losses. Upon adoption, the Company changed the impairment model to utilize a forward-looking current expected credit losses (CECL) model in place of the incurred loss methodology for financial instruments measured at amortized cost and receivables resulting from the application of ASC 606, including contract assets.

 

The Company maintains an allowance for credit losses and records the allowance for credit losses as an offset to accounts receivable and the estimated credit losses charged to the allowance is classified as “General and administrative expenses” in the unaudited condensed consolidated statements of loss and comprehensive loss. The Company assesses collectability by reviewing accounts receivable on aging schedules because the accounts receivable were primarily consisted of receivables arising from product sales. In determining the amount of the allowance for credit losses, the Company considers historical collectability based on past due status, the age of the balances, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect the Company’s ability to collect from customers. Delinquent account balances are written-off against the allowance for expected credit loss after management has determined that the likelihood of collection is not probable.

 

Accounts receivable consisted of the following as of the date indicated:

 

  

March 31,

2026

  

December 31,

2025

 
         
Accounts receivable  $2,457,617    2,445,503 
Less: Allowance for credit losses   (379)   (258)
Total accounts receivable, net  $2,457,238    2,445,245 

 

Expected credit losses (reversal) provision consisted for the following as of the dated indicated:

  

  

March 31,

2025

  

December 31,

2025

 
         
Balance – January 1  $258    367 
Expected (reversal) of credit losses   121    (109)
Balance – December 31  $379    258 

 

The expected credit (reversal) losses provision for the three months ended March 31, 2026 and December 31, 2025 was $121 and ($109), respectively.

 

Advances to Suppliers

 

Advances to suppliers represent amounts paid to suppliers in advance for goods that are yet to be delivered and from which future economic benefits are expected to flow to the Company within the normal operating cycle. Based on its historical record and in normal circumstances, the Company receives goods within 4 to 6 months from the date the advance payment is made. During the three months ended March 31, 2026 and December 31, 2025, no provision was made on advances to suppliers.

 

9

Table of Contents

 

Inventories

 

Inventories consist of finished goods. Inventory costs include the purchase price and other expenditures that are directly attributable to bringing the inventories to their present location and condition. Cost of inventories are computed using the weighted average cost method. Inventories are written down to estimated net realizable value, which considers historical usage, expected demand, anticipated sales price, and other factors. The Company periodically reviews its inventories for excess or slow-moving items and makes provisions as necessary to properly reflect inventory value. For the three months ended March 31, 2026 and 2025, the Company wrote down (reversal) $2,354 and $3,681 of slow-moving inventory, respectively. The inventory write-down is included in “Cost of Sales” from operations in the consolidated statements of loss and comprehensive loss.

 

Property, Plant, and Equipment

 

Property, plant and equipment are stated at cost, net of accumulated depreciation and impairment losses, if any. Expenditures for maintenance and repairs are expensed as incurred, while additions, renewals and improvements are capitalized. When property, plant and equipment are retired or otherwise disposed of, the related cost and accumulated depreciation is removed from the respective accounts, and any gain or loss is included in consolidated statements of loss and comprehensive loss. Depreciation of property, plant and equipment is provided using the straight-line method for substantially all assets with no salvage value and estimated lives as follows:

 

Category  Estimated useful lives 
Computer and office equipment   5 - 10 years 
Decoration and renovation   5 - 10 years 

 

Investment in Funds (Non-Marketable Investments)

 

For the three months ended March 31, 2026 and December 31, 2025, the Company invested $25.86 million and $22.82 million, respectively, in Preamble Capital LLC as equity investment, without significant influence and control, are classified as investment in fund and as level 3 the fair-value hierarchy. In making these estimates, the Company utilized valuation methods based on information available, including the most current purchasing prices and observable transactions such as new offerings. A gain of approximately $0.79 million was recorded in “Other expense, net” in our consolidated statement of loss and comprehensive loss.

 

As of March 31, 2026 and December 31, 2025, these funds measured at fair value were $26.95 million and $23.10 million, respectively, with changes recognized in “Other expenses, net” on our unaudited condensed consolidated statements of loss and comprehensive loss. These funds are classified as level 3 the fair-value hierarchy. These non-marketable investments are included in “Investment in fund” on our consolidated balance sheets.

 

Impairment of Long-Lived Assets

 

Long-lived assets, which include property, plant and equipment and right-of-use assets, are reviewed for impairment whenever events or changes in circumstances indicate the carrying amount of an asset may not be recoverable.

 

Recoverability of long-lived assets to be held and used is measured by comparing the carrying amount of an asset to the estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated undiscounted future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the assets. Fair value is generally determined using the asset’s expected future discounted cash flows or market value, if readily determinable.

 

The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the asset’s carrying amount may not be recoverable. The Company conducts its long-lived asset impairment analyses in accordance with ASC 360-10-15, “Impairment or Disposal of Long-Lived Assets.” ASC 360-10-15 requires the Company to group assets and liabilities at the lowest level for which identifiable cash flows are largely independent of the cash flows of other assets and liabilities and evaluate the asset group against the sum of the undiscounted future cash flows. If the undiscounted cash flows do not indicate the carrying amount of the asset is recoverable, an impairment charge is measured as the amount by which the carrying amount of the asset group exceeds its fair value based on discounted cash flow analysis or appraisals. As of December 31, 2025, the Company determined that goodwill was impaired because of the current financial condition of the Company and the Company’s inability to generate future operating income without substantial sales volume increases, which are highly uncertain. Furthermore, the Company anticipates future cash flows indicate that the recoverability of goodwill is not reasonably assured.

 

10

Table of Contents

 

Research and Development

 

Research and development costs are related primarily to the Company designing and testing its new products during the development stage. Since 2023, the Company through Nova Malaysia has been developing Virtual and Augmented reality software and AI system for potential consulting business. In addition, since 2024, the Company acquired IT systems for AI-Calculation Engine, Nova Living DesignXperience System and Payment IT System which were integrated into our current IT system. The entire system was far from complete as it required to integrate with other components in order to be functional and it was not in operation and was eventually abandoned due to the close down of the business of Nova Malaysia. Research and development expenses were $0 and $390 for the three months ended March 31, 2026 and 2025, respectively.

 

Income Taxes 

 

Income taxes are accounted for using an asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

In its interim financial statements, the Company follows the guidance in ASC 270 “Interim reporting” and ASC 740 “Income Taxes” whereby the Company utilizes the expected annual effective rate in determining its income tax provision. The income tax (expense) benefit for the three months ended March 31, 2026 and 2025 are $0 and $62,260, respectively.

 

The Company follows ASC Topic 740, which prescribes a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740 also provides guidance on recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, accounting for income taxes in interim periods, and income tax disclosures.

 

Under the provisions of ASC Topic 740, when tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

 

XMax Inc. (formerly Nova Lifestyle, Inc.), Diamond Bar and I Design are subject to U.S. federal and state income taxes. Nova Furniture BVI was incorporated in the BVI, Xmax Capital and Nova Samoa were incorporated in Samoa. Xmax Alpha Holdings Ltd, Xmax Beta Holdings Ltd, Xmax Delta Holdings Ltd and Xmax Sigma Holdings Ltd were incorporated in Cayman Islands. There is no income tax for companies domiciled in the BVI, Cayman Islands and Samoa. Accordingly, the Company’s consolidated financial statements do not present any income tax provisions related to the BVI, Cayman Islands and Samoa tax jurisdictions where Nova Furniture BVI, Nova Samoa, Xmax Capital, Xmax Alpha Holdings Ltd, Xmax Beta Holdings Ltd, Xmax Delta Holding Ltd and Xmax Sigma Holdings Ltd are domiciled. Nova Malaysia is incorporated in Malaysia and ceased business operations. Nova Malaysia completed its de-registration with the Malaysian government in the first quarter of 2026.

 

11

Table of Contents

 

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the U.S. The OBBBA extends permanently, with modifications, tax provisions enacted as part of the 2017 Tax Cuts and Jobs Act and restores and makes permanent many business provisions, such as full expensing for domestic research and development and capital investments. In addition, the OBBBA makes changes to certain U.S. corporate tax provisions, but many are generally not effective until 2026. The enactment of the OBBBA does not have a material impact on the results from operations for the current period.

 

The Tax Cuts and Jobs Act of 2017 (the “Act”) created new taxes on certain foreign-sourced earnings such as global intangible low-taxed income (“GILTI”) under IRC Section 951A, which is effective for the Company for tax years beginning after January 1, 2018. For tax years beginning after December 31, 2025, the One Big Beautiful Bill Act renamed GILTI as net CFC tested income (“NCTI”) and modified the Section 951A calculation. For the quarter ended March 31, 2026, the Company has calculated its best estimate of the impact of NCTI, if any, in its income tax provision in accordance with applicable tax law and guidance available as of the date of this filing.

 

The Tax Cuts and Jobs Act of 2017 also amended IRC Section 174 to require specified research and experimental expenditures to be capitalized and amortized for tax years beginning after December 31, 2021. The One Big Beautiful Bill Act subsequently restored current expensing for domestic research and experimental expenditures paid or incurred in tax years beginning after December 31, 2024, while foreign research and experimental expenditures remain subject to capitalization and amortization over 15 years. For the three months ended March 31, 2026, the Company expensed current-year U.S. research and experimental expenditures for federal income tax purposes. The Company did not elect to accelerate the deduction of unamortized domestic research and experimental expenditures from prior years and continues to amortize such amounts over the remaining applicable amortization period. Since the Company’s research and experimental expenditures were incurred within the United States and the amount is immaterial, the Company does not anticipate a material impact to its income tax provision.

 

As of March 31, 2026 and December 31, 2025, the accumulated undistributed earnings generated by its foreign subsidiaries were approximately $21.7 million and $21.7 million of which substantially all was previously subject to U.S. tax, the one-time transition tax on foreign unremitted earnings required by the Tax Act, GILTI, or NCTI, as applicable. Those earnings are considered to be permanently reinvested and accordingly, no deferred tax expense is recorded for U.S. federal and state income tax or applicable withholding taxes.

 

As of March 31, 2026, unrecognized tax benefits were approximately $0. The total amount of unrecognized tax benefits that, if recognized, would favorably affect the effective tax rate was $0 as of March 31, 2026. As of March 31, 2025, unrecognized tax benefits were approximately $0. The total amount of unrecognized tax benefits that, if recognized, would favorably affect the effective tax rate was $0 as of March 31, 2025.

 

A reconciliation of unrecognized tax benefits excluding interest and penalties (“Gross UTB”) for the three months ended March 31, 2026 and 2025, is as follows:

 

       
   Gross UTB 
   2026   2025 
Balance – January 1   -    - 
Foreign exchange adjustment   -    - 
Balance – March 31  $-   $- 

 

As of March 31, 2026 and December 31, 2025, the Company had cumulatively accrued approximately $0 and $0 for estimated interest and penalties related to unrecognized tax benefits. The Company recorded interest and penalties related to unrecognized tax benefits as a component of income tax (benefit)/expense, which totaled $0 and $0 for the three months ended March 31, 2026 and 2025, respectively; and $0 and $0 for the three months ended March 31, 2025, and 2024, respectively, related to the Company’s continuing operations. The Company does not anticipate any significant changes to its unrecognized tax benefits within the next 12 months.

 

XMax Inc. (formerly Nova Lifestyle, Inc.), Diamond Bar and I Design are subject to U.S. federal and state income taxes and tax years 2020-2024 remain open to examination by tax authorities in the U.S.

 

Revenue Recognition

 

The Company recognizes revenues when its customers obtain control of promised goods or services, in an amount that reflects the consideration which it expects to receive in exchange for those goods. The Company recognizes revenues following the five-step model prescribed under ASC-606: (i) identifies contract(s) with a customer; (ii) identifies the performance obligations in the contract; (iii) determines the transaction price; (iv) allocates the transaction price to the performance obligations in the contract; and (v) recognizes revenues when (or as) it satisfies the performance obligation.

 

Revenue from product sales is recognized when the customer obtains control of our product, which typically occurs upon shipment to the customer. Each customer order is being distinct and separately identifiable from other customer orders as a single performance obligation to deliver the ordered product in exchange for consideration. The Company offers credit sales to customers with credit periods range from 30 to 90 days. We expense incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that it would have recognized is one year or less or the amount is immaterial.

 

Product revenue reserves, which are classified as a reduction in product revenues, are generally characterized in the following categories: discounts, returns and rebates. These reserves are based on estimates of the amounts earned or to be claimed on the related sales and are classified as reductions of accounts receivable as the amount is payable to the Company’s customer.

 

12

Table of Contents

 

The Company’s sales policy allows for product returns within the warranty period if the product is defective and the defects are the Company’s fault. As alternatives to the product return option, the customers have the option of requesting a discount from the Company for products with quality issues or of receiving replacement parts from the Company at no cost. The amount for product returns, the discount provided to the Company’s customers, and the costs for replacement parts were immaterial for the three months ended March 31, 2026 and 2025.

 

The Company considers itself acting as a principal for sales of goods which is evidenced by (i) the Company is primarily responsible for fulfilling the promise to provide the specified goods, (ii) the Company has inventory risk before the specified goods have been transferred to a customer or after transfer of control to the customer, (iii) the Company has discretion in establishing the price for the specified good. Thus, the Company’s’ revenue is recognized at a point in time when a promised good is delivered to a customer.

 

Cost of Sales

 

Cost of sales consists primarily of costs of finished goods purchased from third-party manufacturers and write-downs of inventory.

 

Shipping and Handling Costs

 

Shipping and handling costs related to delivery of finished goods are included in selling expenses. During the three months ended March 31, 2026 and 2025, shipping and handling costs were $0 and ($2,033) respectively.

 

Advertising

 

Advertising expenses consist primarily of costs of promotion and marketing for the Company’s image and products, and costs of direct advertising, and are included in selling expenses. The Company expenses all advertising costs as incurred. Advertising expense was $101,986 and $15,380 for the three months ended March 31, 2026 and 2025, respectively.

 

Share-based Compensation

 

The Company applies ASC 718 (“ASC 718”), Compensation - Stock Compensation, to account for its employee share-based payments. In accordance with ASC 718 -10, the share-based payment transactions with employees and non-employees, such as share options, be measured based on the grant-date fair value of the equity instrument issued and recognized as compensation expense over the requisite service period, with a corresponding addition to equity. Under this method, compensation cost related to employee share options or similar equity instruments is measured at the grant date based on the fair value of the award and is recognized over the period during which an employee is required to provide service in exchange for the award, which generally is the vesting period. Unrestricted stock awards are fully vested upon issuance, and compensation expense is recognized equal to the fair value of the award on the grant date. The fair value of unrestricted stock is determined based on the closing market price of the Company’s common stock on the grant date.

 

Earnings per Share (EPS)

 

Basic EPS is computed by dividing net income by the weighted average number of common shares outstanding for the period. Diluted EPS is computed similar to basic net income per share except that the denominator is increased to include the number of additional common shares that would have been outstanding if all the potential common shares pertaining to warrants, stock options, and similar instruments had been issued and if the additional common shares were dilutive. Diluted earnings per share are based on the assumption that all dilutive convertible shares and stock options and warrants were converted or exercised. Dilution is computed by applying the treasury stock method for the outstanding unvested restricted stock, options and warrants, and the if-converted method for the outstanding convertible instruments. Under the treasury stock method, options and warrants are assumed to be exercised at the beginning of the period (or at the time of issuance, if later) and as if funds obtained thereby were used to purchase common stock at the average market price during the period. Under the if-converted method, outstanding convertible instruments are assumed to be converted into common stock at the beginning of the period (or at the time of issuance, if later).

 

13

Table of Contents

 

The following table presents a reconciliation of basic and diluted loss per share for the three months ended March 31, 2026 and 2025:

 

   2026   2025 
         
Net income (loss)  $191,514   $(338,871)
           
Weighted average shares outstanding – Basic and Diluted *   44,829,706    9,780,576 
           
Net loss per share of common stock          
Basic and Diluted  $0.00   $(0.03)

 

* Including 10,458,000 and 501,550 shares that were granted and vested but not yet issued for the three months ended March 31, 2026 and 2025, respectively.

 

For the three months ended March 31, 2026 and 2025, 0 and 3,000 shares of unvested restricted stock and 1,494,588 and 245,192 shares exercisable under warrants were excluded from the EPS calculation, as their effect were anti-dilutive.

 

Concentration of Credit Risk

 

Financial instruments that potentially subject the Company to credit risk consist primarily of accounts receivable, other receivables and investment in funds. The Company does not require collateral or other security to support these receivables. The Company conducts periodic reviews of the financial condition and payment practices of its customers to minimize collection risk on accounts receivable.

 

The following table sets forth information as to the Company’s customers that accounted for 10% or more of the Company’s sales and accounts receivable for the three months ended March 31, 2026 and 2025.

 

Three Months Ended

March 31, 2026

 

As of

March 31, 2026

 
Customer 

Percentage of

Total Sales

  

Percentage of

accounts receivable

 
A   2%   1%

 

Three Months Ended

March 31, 2025

 

As of

March 31, 2025

 
Customer 

Percentage of

Total Sales

  

Percentage of

accounts receivable

 
A   2%   14%

 

No customer accounted for 10% or more of the Company’s sales for the three months ended March 31, 2026 and 2025, respectively.

 

No customer and one customer accounted for 10% or more of the Company’s gross accounts receivable for the three months ended March 31, 2026 and 2025. One customer accounted for 14% of the Company’s gross accounts receivable as of March 31, 2025.

 

14

Table of Contents

 

The following table sets forth information as to the Company’s suppliers that accounted for 10% or more of the Company’s total purchases, accounts payable and advance to suppliers for the three months ended March 31, 2026 and 2025.

 

Three Months Ended

March 31, 2026

 

As of

March 31, 2026

  

As of

March 31, 2026

 
Supplier 

Percentage of

Total Purchases

  

Balance of

Accounts Payable

  

Balance of

Advance to Supplier

 
A   16%  $48,010    - 
B   5%   13,077    - 
C   2%   -    - 
D   5%   28,300    - 

 

Three Months Ended

March 31, 2025

 

As of

March 31, 2025

  

As of

March 31, 2025

 
Supplier 

Percentage of

Total Purchases

  

Balance of

Accounts Payable

  

Balance of

Advance to Supplier

 
A   11%  $100,428    - 
B   1%   -    - 
C   3%   44,882    - 
D   5%   13,740    - 

 

The Company purchased its products from one major vendor during the three months ended March 31, 2026 and 2025, respectively, accounting for a total of 16% for 2026 and 11% for 2025 of the Company’s purchases, respectively.

 

Accounts payable to these major vendors were $89,387 and $159,050 as of March 31, 2026 and 2025, respectively.

 

Advances made to these major vendors were $0 as of March 31, 2026 and 2025, respectively.

 

Fair Value of Financial Instruments

 

ASC Topic 820, “Fair Value Measurements and Disclosures,” requires disclosure of the fair value of financial instruments held by the Company. ASC Topic 825, “Financial Instruments,” defines fair value and establishes a three-level valuation hierarchy for disclosures of fair value measurement that enhances disclosure requirements for fair value measures. The carrying amounts reported in the condensed consolidated balance sheets for receivables and current liabilities each qualify as financial instruments and are a reasonable estimate of their fair values because of the short period of time between the origination of such instruments and their expected realization and their current market rate of interest. The three levels of valuation hierarchy are defined as follows:

 

Level 1 inputs to the valuation methodology are quoted prices (unadjusted) for identical assets or liabilities in active markets.
   
Level 2 inputs to the valuation methodology include quoted prices for similar assets and liabilities in active markets, and inputs that are observable for the asset or liability, either directly or indirectly, for substantially the full term of the financial instrument.
   
Level 3 inputs to the valuation methodology are unobservable and significant to the fair value measurement.

 

The carrying value of cash and cash equivalents, accounts receivable, other receivables, accounts payable, other payables and accrued liabilities approximate estimated fair values because of their short maturities.

 

The carrying amount of the borrowing approximates its fair values since it bears an interest rate which approximates market interest rate.

 

15

Table of Contents

 

Foreign Currency Translation and Transactions

 

The accompanying consolidated financial statements are presented in United States Dollar (“$” or “USD”), which is also the functional currency of XMAX (Nova LifeStyle), Nova Furniture, Nova Samoa, Diamond Bar, I Design, Xmax Capital, Xmax Alpha Holdings Ltd, Xmax Beta Holdings Ltd, Xmax Delta Holdings Ltd and Xmax Sigma Holdings Ltd.

 

The Company’s subsidiary with operations in Malaysia uses its local currency, the Malaysian Ringgit (“RM”), as its functional currency. An entity’s functional currency is the currency of the primary economic environment in which it operates, which is the currency of the environment in which the entity primarily generates and expends cash. Management’s judgment is essential to determine the functional currency by assessing various indicators, such as cash flows, sales price and market, expenses, financing and inter-company transactions and arrangements.

 

Foreign currency transactions denominated in currencies other than the functional currency are translated into the functional currency using the exchange rates prevailing at the dates of the transactions. Monetary assets and liabilities denominated in foreign currencies at the balance sheet date are re-measured at the applicable rates of exchange in effect at that date. Gains and losses resulting from foreign currency re-measurement are included in the statements of operations.

 

The financial statements are presented in U.S. dollars. Assets and liabilities are translated into U.S. dollars at the current exchange rate in effect at the balance sheet date, and revenues and expenses are translated at the average of the exchange rates in effect during the reporting period. Stockholders’ equity accounts are translated using the historical exchange rates at the date the entry to stockholders’ equity was recorded, except for the change in retained earnings during the period, which is translated using the historical exchange rates used to translate each period’s income statement. Differences resulting from translating functional currencies to the reporting currency are recorded in accumulated other comprehensive income in the balance sheets.

 

Translation of amounts from RM into U.S. dollars has been made at the following exchange rates:

 

Balance sheet items, except for equity accounts     
March 31, 2026   - 
December 31, 2025   RM 4.06 to 1 
      
Income Statement and cash flow items     
For the three months ended March 31, 2026   - 
For the three months ended March 31, 2025   RM 4.45 to 1 

 

Segment Reporting

 

An operating segment is a component of the Company that engages in business activities from which it may earn revenue and incur expenses and is identified on the basis of the internal financial reports that are provided to and regularly reviewed by the Company’s chief operating decision maker in order to allocate resources and assess performance of the segment.

 

In accordance with ASC 280, Segment Reporting, operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (“CODM”), in deciding how to allocate resources and in assessing performance. The Company’s revenue segments have similar economic characteristics and they are managed as a single business unit. The Company uses the “management approach” in determining reportable operating segments. The management approach considers the internal organization and reporting used by the Company’s chief operating decision maker for making operating decisions and assessing performance as the source for determining the Company’s reportable segments. The Company’s CODM has been identified as the chief executive officer (the “CEO”), who reviews consolidated results when making decisions about allocating resources and assessing performance of the Company. The Company has determined that there is only one reportable operating segment.

 

Management concluded that the Company had one reportable segment under ASC 280 because Diamond Bar is a furniture distributor based in California focusing on customers in the United States and Nova Malaysia is a furniture retailer and distributor focusing on customers primarily in Malaysia. They are all operated under the same senior management of the Company, and management views the operations of Diamond Bar and Nova Malaysia as one entity for making business decisions.

 

All of the Company’s long-lived assets are mainly property, plant and equipment located in the United States and Malaysia and are utilized for administrative purposes.

 

16

Table of Contents

 

Sales to customers by geographic area are determined by reference to the physical product shipment delivery locations requested by the customers. For example, if the products are delivered to a customer in the United States, the sales are recorded as generated in the United States; if the customer directs us to ship its products to China, the sales are recorded as sold in China. The Geographical Analysis is disclosed in Note 15.

 

Leases

 

The Company determines if an arrangement is a lease or contains a lease at inception. A contract is or contains a lease if it conveys the right to control the use of an identified asset for a period of time in exchange of a consideration. To assess whether a contract is or contains a lease, the Company assess whether the contract involves the use of an identified asset, whether it has the right to obtain substantially all the economic benefits from the use of the asset and whether it has the right to control the use of the asset.

 

The right-of-use assets and related lease liabilities are recognized at the lease commencement date. The Company recognizes operating lease expenses on a straight-line basis over the lease term.

 

Right-of-use of assets

 

The Company recognizes right-of-use assets at the commencement date of the lease (i.e. the date the underlying asset is available for use). Right-of-use assets are measured at cost, less any accumulated depreciation and impairment losses and adjusted for any remeasurement of lease liabilities. The cost of right-of-use assets includes the amount of lease liabilities recognized, initial direct costs incurred, and lease payments made at or before the commencement date less any lease incentives received. Right-of-use assets are depreciated on a straight-line basis over the shorter of the lease term and the estimated useful lives of the assets. All right-of-use assets are reviewed for impairment annually. There was no impairment for right-of-use lease assets for the three months ended March 31, 2026 and December 31, 2025.

 

Lease liabilities

 

Lease liability is initially measured at the present value of the outstanding lease payments at the commencement date, discounted using the Company’s incremental borrowing rate. Lease payments included in the measurement of the lease liability comprise fixed lease payments, variable lease payments that depend on an index or a rate, amounts expected to be payable under a residual value guarantee and any exercise price under a purchase option that the Company is reasonably certain to exercise. Lease liability is measured at amortized cost using the effective interest rate method. It is re-measured when there is a change in future lease payments, if there is a change in the estimate of the amount expected to be payable under a residual value

 

The operating lease is included in operating lease right-of-use assets, operating lease liabilities-current and operating lease liabilities-non-current on the consolidated balance sheets at March 31, 2026 and December 31, 2025.

 

Convertible Note

 

The Company accounts for convertible notes in accordance with ASC 470-20, Debt with Conversion and Other Options. The notes are initially recorded at their principal amount, net of any applicable debt issuance costs. The Company evaluates the conversion features of its debt instruments to determine whether those features require bifurcation and separate accounting as derivatives.

 

For convertible notes issued with a conversion price that is fixed and where the conversion feature is considered clearly and closely related to the host contract, the instrument is accounted for as a single liability. Interest expense is recognized using the effective interest method over the term of the note. Upon conversion, the carrying value of the debt is reclassified to stockholders’ equity, and no gain or loss is recognized.

 

17

Table of Contents

 

Accounts Payable and other payables

 

Accounts payable and other payables represent obligations to pay for goods or services that have been acquired in the ordinary course of business. These liabilities are recognized when the Company becomes a party to the contractual provisions of the instrument, typically when legal title to goods passes or services are rendered.

 

Payables are initially measured at their transaction price, which represents the undiscounted amount of cash expected to be paid to satisfy the obligation. The Company classifies these as current liabilities unless the payment is not due within twelve months after the reporting period.

 

Other loan and borrowing cost

 

Other loans and borrowings are initially recognized at fair value, net of transaction costs incurred. Subsequent to initial recognition, these interest-bearing obligations are measured at amortized cost using the effective interest method.

 

Borrowing costs that are directly attributable to the acquisition, construction, or production of a qualifying asset are capitalized as part of the cost of that asset. All other borrowing costs are expensed in the period in which they are incurred. Debt issuance costs are presented in the balance sheet as a direct reduction from the carrying amount of the related debt liability and are amortized as interest expense over the term of the loan.

 

Contract liabilities

 

The Company accounts for contract liabilities under ASC 606, Revenue from Contracts with Customers. These amounts represent the Company’s obligation to transfer goods or services to a customer for which the Company has received consideration (or an amount of consideration is due) from the customer.

 

Advances are recorded as a contract liability at the time of receipt. The Company recognizes these advances as revenue when (or as) the Company satisfies its performance obligations under the terms of the contract. The Company evaluates the timing of satisfaction (point-in-time vs. over-time) based on the transfer of control to the customer. The Company’s contract liabilities amounted to $89,147 and $58,786 as of March 31, 2026 and December 31, 2025, respectively. The Company expects to recognize this balance as revenue over the next 12 months.

 

Reclassification

 

Certain prior period accounts have been reclassified in conformity with current period’s presentation.

 

New Accounting Pronouncements

 

Recently Adopted Accounting Standards

 

In March 2025, the FASB issued ASU 2025-02—Liabilities (405): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 122. The amendments in this Update are effective immediately and on a fully retrospective basis to annual periods beginning after December 15, 2024. The Company adopted the ASU in 2025. The adoption did not have a material impact on the financial statements.

 

On July 4, 2025, the U.S. H.R.1, an act to provide for reconciliation pursuant to title II of H. Con. Res. 14. (the “OBBBA”) was enacted. The OBBBA introduces multiple tax law and other legislative changes, including modifications to income tax provisions such as domestic research and development expenses, capital expenditures, and U.S. taxation of international earnings; the repeal or acceleration of the sunset of certain tax credits under the 2022 Inflation Reduction Act and elimination of certain penalties for violations of certain regulatory credit programs. We have recognized the effects of the OBBBA provisions in our financial results to the extent they are applicable to the three months ended March 31, 2026. We will continue to evaluate the impact of these provisions on our 2026 and subsequent consolidated financial statements, including loss of certain regulatory credit sales tied to our products and changes to the costs of our products.

 

In March 2023, the FASB issued ASU 2023-01, Lease (Topic 842): Common Control Arrangements, which clarifies the accounting for leasehold improvements associated with leases between entities under common control (hereinafter referred to as common control lease). ASU 2023-01 requires entities to amortize leasehold improvements associated with common control lease over the useful life to the common control group (regardless of the lease term) as long as the lessee controls the use of the underlying asset through a lease, and to account for any remaining leasehold improvements as a transfer between entities under common control through an adjustment to equity when the lessee no longer controls the underlying asset. This ASU will be effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been made available for issuance. An entity may apply ASU 2023-01 either prospectively or retrospectively. The Company is currently evaluating the impact that the adoption of ASU 2023-01 will have on our unaudited condensed consolidated financial statement presentations and disclosures.

 

18

Table of Contents

 

In December 2023, the FASB issued Accounting Standards Update No.2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation,(2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3)income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual period beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its unaudited condensed consolidated financial statements and related disclosures.

 

In July 2025, the FASB issued ASU 2025-05, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. The amendments provide a practical expedient and, if applicable, an accounting policy election to simplify the measurement of credit losses for certain receivables and contract assets. The amendments are effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted in any interim or annual period in which financial statements have not been issued or made available for issuance. The Company is currently evaluating the impact of this amendment and does not expect that the adoption of this guidance will have a material impact on its financial position, results of operations, or cash flows.

 

Recently Issued But Not Yet Adopted Accounting Pronouncements

 

On November 4, 2024, the FASB issued an ASU No. 2024-03, Disaggregation of Income Statement Expenses (“ASU 2024 03”) to improve the disclosures about a public business entity’s expenses and address requests from investors for more detailed information about the types of expenses in commonly presented expense captions (such as cost of sales; selling, general, and administrative expenses; and research and development). The amendments in the ASU require disclosure in the notes to financial statements of specified information about certain costs and expenses. The amendments require that at each interim and annual reporting period an entity: 1. Disclose the amounts of (a) purchases of inventory, (b) employee compensation, (c) depreciation, (d) intangible asset amortization, and (e) depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities (or other amounts of depletion expense) included in each relevant expense caption. A relevant expense caption is an expense caption presented on the face of the income statement within continuing operations that contains any of the expense categories listed in (a)–(e). 2. Include certain amounts that are already required to be disclosed under current generally accepted accounting principles in the same tabular disclosure as the other disaggregation requirements. 3. Disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. 4) Disclose the total amount of selling expenses and, in annual reporting periods, an entity’s definition of selling expenses. In January 2025, the FASB issued ASU No. 2025-01, Clarifying the Effective Date (“ASU 2025-01”). The amendments, as clarified by ASU 2025-01, are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The amendments in this ASU should be applied either (1) prospectively to financial statements issued for reporting periods after the effective date of the ASU or (2) retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the impact that the adoption of ASU 2024-03 will have on its consolidated financial statement presentation or disclosures.

 

In January 2025, the FASB issued ASU 2025-01 Income Statement-Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40). The FASB issued ASU 2024-03 on November 4, 2024-03 states that the amendments are effective for public business entities for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Following the issuance of ASU 2024-03, the FASB was asked to clarify the initial effective date for entities that do not have an annual reporting period that ends on December 31 (referred to as non-calendar year-end entities). Because of how the effective date guidance was written, a non-calendar year-end entity may have concluded that it would be required to initially adopt the disclosure requirements in ASU 2024-03 in an interim reporting period, rather than in annual reporting period. The FASB’s intent in the basis for conclusions of ASU 2024-03 is clear that all public business entities should initially adopt the disclosure requirements in the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027.

 

19

Table of Contents

 

In May 2025, the FASB issued ASU 2025-03, Business Combinations (Topic 805) and Consolidation (Topic 810): Determining the Accounting Acquirer in the Acquirer in the Acquisition of a Variable Interest Entity. The amendments provide guidance on identifying the accounting acquirer in transactions involving a variable interest entity. The amendments are effective for annual reporting periods beginning after December 15, 2026, and interim reporting period within those annual periods. Early adoption is permitted as of the beginning of an interim or annual reporting period. The Company is currently evaluating the impact of this amendment and does not expect that the adoption of this guidance will have a material impact on its financial position, results of operations, or cash flows.

 

In May 2025, the FASB issued ASU 2025-04, Compensation - Stock Compensation (Topic 18) and Revenue from contracts with Customers (Topic 606): Clarifications to Share-Based Consideration Payable to a Customer. The amendments provide guidance on identifying the accounting acquirer in transactions involving a variable interest entity. The amendments clarify the accounting for share-based consideration payable to a customer under Topic 718 and Topic 606. The amendments are effective for annual reporting periods, including interim reporting period within those annual periods, beginning after December 15, 2026. Early adoption is permitted. The Company is currently evaluating the impact of this amendment and does not expect that the adoption of this guidance will have a material impact on its financial position, results of operations, or cash flows.

 

In September 2025, the FASB issued ASU No. 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. The ASU simplifies the capitalization guidance by removing all references to prescriptive and sequential software development stages (referred to as “project stages”) throughout ASC 350-40. The ASU is effective for annual periods beginning after December 15, 2027, and interim periods within those fiscal years. Adoption of this ASU can be applied prospectively for reporting periods after its effective date; or follow a modified transition approach that is based on the status of the respective projects and whether software costs were capitalized before the date of adoption; or retrospectively to any or all prior periods presented in the consolidated financial statements. Early adoption is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.

 

In December 2025, the FASB issued ASU No. 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities. The ASU establishes authoritative guidance in GAAP about accounting for government grants received by business entities, clarifies the appropriate accounting, in an effort to reduce diversity in practice, and increase consistency of application across business entities. The ASU is effective for annual reporting periods beginning after December 15, 2028, and interim reporting periods within those annual reporting periods. Adoption of this ASU can be applied a modified prospective approach, a modified retrospective approach, or a retrospective approach. Early adoption is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.

 

In December 2025, the FASB issued ASU No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. The ASU clarifies interim disclosure requirements and the applicability of Topic 270. The objective of the amendments is to provide further clarity about the current interim disclosure requirements. The ASU is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. Adoption of this ASU can be applied either a prospective or a retrospective approach. Early adoption is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.

 

20

Table of Contents

 

In December 2025, the FASB issued ASU No. 2025-12, Codification Improvements. The ASU addresses thirty-three items, representing the changes to the Codification that (1) clarify, (2) correct errors, or (3) make minor improvements. Generally, the amendments in this Update are not intended to result in significant changes for most entities. The ASU is effective for interim reporting periods within annual reporting periods beginning after December 15, 2026. The adoption method of this ASU may vary, on an issue-by-issue basis. Early adoption is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.

 

In April 2026, the FASB issued ASU 2026-01—Equity (Topic 505): Initial Measurement of Paid-in-Kind Dividends on Equity-Classified Preferred Stock. The amendments in this Update clarify the initial measurement of paid-in-kind dividends on preferred stock that is classified within equity. The amendments in this Update are effective for all entities for annual reporting periods beginning after December 15, 2026, and interim reporting periods within those annual reporting periods. Early adoption is permitted in any interim or annual reporting period in which financial statements have not yet been issued or made available for issuance. An entity adopting the amendments in an interim reporting period should apply them as of the beginning of the annual reporting period that includes that interim reporting period. The Company is currently evaluating the impact that the adoption of ASU 2026-01 will have on its consolidated financial statement presentation or disclosures.

 

The Company’s management does not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact on the Company’s financial statement presentation or disclosures.

 

Note 3 - Inventories

 

The inventories as of March 31, 2026 and December 31, 2025 totaled $1,656,675 and $2,163,437, respectively, and consisted entirely of finished goods.

 

Inventories are stated at the lower of cost and net realizable value, with cost determined on a weighted-average basis. Write-down of potential obsolete or slow-moving inventories is recorded based on management’s assumptions about future demands and market conditions. For the three months ended March 31, 2026 and 2025, the Company wrote-down (reversed) $2,354 and $3,681 of slow-moving inventory, respectively. The inventory write-down is included in “Cost of Sales” in the consolidated statements of loss and comprehensive loss.

 

Note 4 – Plant, property and Equipment, Net

 

As of March 31, 2026 and 2025, Plant, property and equipment consisted of the following:

 

  

March 31,

2026

  

December 31,

2025

 
Computer and office equipment  $189,172   $195,826 
Decoration and renovation   43,400    43,400 
Property plant and equipment gross   232,572    239,226 
Less: accumulated depreciation   (212,718)   (217,284)
Property plant and equipment net  $19,854   $21,942 

 

On October 1, 2025, Nova Malaysia abandoned its entire fixed assets of 819,649 Malaysia Ringgit ($191,466) without cash consideration.

 

Depreciation expense was $2,088 and $14,495 for the three months ended March 31, 2026 and 2025, respectively.

 

Note 5 – Intangible Assets

 

As of March 31, 2026 and December 31, 2025, intangible assets consisted of the following:

 

  

March 31,

2026

  

December 31,

2025

 
Accounting software  $26,800   $26,800 
Less: accumulated amortization   (26,800)   (26,800)
Intangible assets, net  $-   $- 

 

Amortization expense was $0 and $1,341 for the three months ended March 31, 2026 and 2025, respectively.

 

21

Table of Contents

 

Note 6 – Investment in Fund

 

On September 25, 2025, Nova Furniture Limited (the “Nova BVI”), a company incorporated in the British Virgin Islands and a wholly owned subsidiary of XMax Inc. entered into a Subscription Agreement (the “Agreement”) with Preamble Capital, A Series of CGF2021 LLC (the “Fund”), a Delaware Limited Liability Company. Pursuant to the Agreement, Nova BVI subscribes 99.815% interest in the Fund in an amount equal to $5,664,500. (the “Subscription Amount”) and will become a member of the Fund and be bound by the LLC Agreement as a member of the Fund. Sydecar LLC, a Delaware limited liability company, is the administrator of the Fund. The applicable management fee percentage for the Company is 0%. The Fund will use the Subscription Amount to subscribe approximately 6.667% interest of certain fund that holds an aggregate of 353,772 shares of Common Stock of Space Exploration Technologies Corp., a Texas corporation (“SpaceX”), comprising of 121,805 shares of Class A Common Stock and 231,967 shares of Class C Common Stock of Space X.

 

On September 25, 2025, Nova BVI closed its subscription of 99.815% interest in Preamble Capital, A Series of CGF2021 LLC (the “Preamble Capital”), a Delaware Limited Liability Company for $5,664,500.

 

On September 26, 2025, Preamble Capital entered into a Subscription Agreement (the “Subscription Agreement”) with a certain fund that holds an aggregate of 353,772 shares of Common Stock of SpaceX, comprising of 121,805 shares of Class A Common Stock and 231,967 shares of Class C Common Stock of Space X. Pursuant to the Subscription Agreement, Preamble Capital subscribed approximately 6.667% interest of such fund for an amount of $5,660,000 (the “Transaction”). On September 29, 2025, Preamble Capital closed the Transaction.

 

On October 15, 2025, XMax Alpha Holdings Ltd. (the “Company”), a company incorporated in the Cayman Islands and an indirectly wholly owned subsidiary of XMax Inc. entered into a Subscription Agreement (the “Agreement”) with Preamble Capital I, A Series of CGF2021 LLC (the “Fund”), a Delaware Limited Liability Company. Pursuant to the Agreement, the Company subscribed 99.82% interest in the Fund in an amount equal to $5,605,000 (the “Subscription Amount”) and has become a member of the Fund and been bound by the LLC Agreement as a member of the Fund. Sydecar LLC, a Delaware limited liability company, is the administrator of the Fund. The applicable management fee percentage for the Company is 0%. October 15, 2025, the Company completed the subscription.

 

On October 16, 2025, the Fund entered into a Subscription Agreement with a certain fund to subscribe certain interest of such fund for an amount of $5,600,000, which will be used by such fund to purchase shares of common stock of SpaceX.

 

On December 2, 2025, Xmax Beta Holdings Ltd. (the “Xmax Beta”), a company incorporated in the Cayman Islands and an indirectly wholly owned subsidiary of XMax Inc. entered into a Subscription Agreement (the “Agreement”) with Preamble X Capital I, a series of Preamble X Capital LLC, a Delaware Limited Liability Company. Pursuant to the Agreement, Xmax Beta subscribed approximately 99.88% interest in Preamble X Capital I in an amount equal to US$8,461,428.80 (the “Subscription Amount”) and has become a member of Preamble X Capital I and been bound by the LLC Agreement as a member of Preamble X Capital I. Allocations Fund Administration, LLC is the administrative manager of Preamble X Capital I. The applicable management fee percentage for Xmax Beta is 0%. On December 2, 2025, Xmax Beta completed the subscription.

 

On December 2, 2025, Preamble X Capital I entered into a Subscription Agreement with a dedicated SPV (the “SPV”) to subscribe 40,106 equity certificates in the SPV for an amount of US$2,999,928.80. The SPV currently holds 502,236 equity certificates, and each certificate is entitled to a share of Series B Preferred Stock of xAI Holdings Corp., a Neveda corporation (“xAI”) and such Series B Preferred Stock of xAI are directly held by a certain fund.

 

On December 8, 2025, Preamble X Capital I entered into a separate Subscription Agreement with a separate fund to subscribe certain interest of such fund for an amount of $5,400,000, which will be used by such fund to purchase shares of common stock of xAI.

 

On December 16, 2025, Xmax Beta entered into a Subscription Agreement (the “Agreement”) with Preamble X Capital I, a series of Preamble X Capital LLC, a Delaware Limited Liability Company. Pursuant to the Agreement, Xmax Beta made an additional subscription in an aggregate amount of US$5,375,000 (the “Subscription Amount”), thereby increasing Xmax Beta’s interest in Preamble X Capital I to approximately 99.9%.

 

22

Table of Contents

 

Allocations Fund Administration, LLC is the administrative manager of Preamble X Capital I. The applicable management fee percentage for Xmax Beta is 0%. On December 17, 2025, Xmax Beta completed the subscription.

 

On December 18, 2025, Preamble X Capital I entered into a Subscription Agreement with a certain fund to subscribe certain interest of such fund for an amount of $5,400,000, which will be used by such fund to purchase shares of xAI.

 

On December 2, 2025, Preamble X Capital I, a series of Preamble X Capital LLC entered into a Subscription Agreement with a dedicated SPV (the “SPV”) to subscribe 40,106 equity certificates in the SPV for an amount of US$2,999,928.80 (the “Transaction”) and the SPV holds 502,236 equity certificates, and each certificate is entitled to a share of Series B Preferred Stock of xAI and such Series B Preferred Stock of xAI are directly held by a certain fund, as previously disclosed in the Form 8-K filed by the Company with SEC on December 8, 2025, amended on December 10, 2025. On December 16, 2025, Preamble X Capital I closed the Transaction.

 

On February 4, 2026, Xmax Beta entered into a Subscription Agreement (the “Agreement”) with Preamble X Capital I, a series of Preamble X Capital LLC, a Delaware Limited Liability Company. Pursuant to the Agreement, Xmax Beta made additional subscription in an aggregate amount of US$3,048,773.60 (the “Subscription Amount”), which increases Xmax Beta’s interest in Preamble X Capital I to approximately 99.9%. Allocations Fund Administration, LLC is the administrative manager of Preamble X Capital I. The applicable management fee percentage for Xmax Beta is 0%. On February 4, 2026, Xmax Beta completed the subscription.

 

On February 4, 2026, Preamble X Capital I entered into a Subscription Agreement with a dedicated SPV (the “SPV”) to subscribe 34,963 equity certificates in the SPV for an amount of US$3,048,773.60. Each certificate is entitled to a share of Series B Preferred Stock of X.AI Holdings Corp., a Nevada corporation (“xAI”), and such Series B Preferred Stock of xAI is directly held by a certain fund.

 

In making these estimates, the company utilized valuation methods based on information available, including the most current purchasing prices and observable transactions such as new offerings. For the three months ended March 31, 2026, A gain of approximately $0.79 million was recorded in “Other income (expense), net” in our consolidated statement of loss and comprehensive loss.

 

As of March 31, 2026 and December 31, 2025, these funds measured at fair value were $26.95 million and $23.10 million, respectively, with changes recognized in “Other expenses, net” on our consolidated statements of loss and comprehensive loss. These funds are classified as level 3 the fair-value hierarchy. These non-marketable investments are included in Investment in fund on our consolidated balance sheets.

 

Note 7 – Advance to Suppliers

 

The Company makes advances to certain vendors for inventory purchases. The advances on inventory purchases were $225,604 and $313,924 as of March 31, 2026 and December 31, 2025, respectively. No impairment charges were made on advance to suppliers for the three months ended March 31, 2026 and the twelve months ended December 31, 2025.

 

Note 8 – Prepaid Expenses and Other Receivables

 

Prepaid expenses and other receivables consisted of the following as of March 31, 2026 and December 31, 2025:

 

  

March 31,

2026

  

December 31,

2025

 
         
Prepaid expenses  $58,492   $144,274 
Other receivables   40,925    7,478 
Prepaid expenses and other receivables  $99,417   $151,752 

 

As of March 31, 2026 and December 31, 2025, prepaid expenses and other receivables mainly represented prepaid insurance, prepaid rent, refund receivable from suppliers, prepaid advertising expense, and Celero and Cardknox account balances.

 

23

Table of Contents

 

Note 9 – Loan to Third Party

 

On January 28, 2026, the Company entered into a loan agreement with a company incorporated in Hong Kong. Pursuant to the Loan Agreement, the Company agreed to provide the borrower with a loan in an aggregate principal amount of $5.3 million. The loan bears interest at a rate equal to 6% per annum and matures on the date that is one year from the funding date of the loan. The loan agreement contains customary representations and warranties, and events of default. For the three months ended March 31, 2026, the Company recorded $54,888 as interest income.

 

Note 10 – Accrued Liabilities and Other Payables

 

Accrued liabilities and other payables consisted of the following as of March 31, 2026 and December 31, 2025:

 

  

March 31,

2025

  

December 31,

2025

 
         
Other payables  $202,962   $563,602 
Salary payable   4,750    4,750 
Financed insurance premiums   16,838    66,767 
Auditing fee   140,000    200,000 
Warranty liability   40,848    32,000 
Accrued commission   886    603 
Accrued expenses, others   50,414    75,590 
Total accrued liabilities and other payable  $456,698   $943,312 

 

As of March 31, 2026 and December 31, 2025, other accrued expenses mainly included legal and professional fees, utilities and unpaid operating expenses incurred in Malaysia. Other payables represented balance on credit card, other taxes payable, 401(k) payable and payable for marketing, shipping, director and showroom.

 

On September 12, 2023, Nova Malaysia entered into an agreement with a consulting firm to deliver consultancy service for AI Trends and Tools. Nova Malaysia agreed to pay 5,000,000 Malaysia Ringgit ($1,065,235) for the service. During 2024, Nova Malaysia paid 4,100,000 Malyaia Ringgit ($896,234) to the consultant and was recorded as consulting expense. The remaining balance was recorded as accrued expenses. On October 31, 2025, Nova Malaysia was forgiving the remaining amount of 900,000 Malaysia Ringgit ($221,893) by the consulting firm and recorded the remaining amount as other income.

 

Note 11 – Other Loan

 

On June 19, 2020, Diamond Bar was granted a U.S. Small Business Administration (SBA) loan in the aggregate amount of $150,000, pursuant to the Economic Injury Disaster Loan. The Loan, which was in the form of a promissory note dated June 19, 2020, matures on June 19, 2050 and bears interest at a rate of 3.75% per annum, payable monthly beginning 12 months from the date of the promissory note. Funds from the Loan may only be used for working capital. The loan was secured by all tangible and intangible property of Diamond Bar and has accumulated interest of $1,295 and $1,327 for the three months ended March 31, 2026 and 2025, respectively.

 

On November 14, 2024, Nova Malaysia entered into a loan agreement in the aggregate amount of $71,286 (equivalent to Malaysia Ringgit 300,000) with an unrelated third party. The loan was in the form of a promissory note dated on November 14, 2024, matures on November 13, 2030, and bears no interest. The proceed of the loan is used for working capital. On October 1, 2025, the lender forgave the loan and record it as other income.

 

24

Table of Contents

 

Note 12 – Convertible Notes

 

On November 18, 2025, the Company entered into a Convertible Promissory Note Purchase Agreement (the “Agreement”) with Billiongold Holding Limited, a company incorporated under the law of Hong Kong (the “Purchaser”). Pursuant to the Agreement, the Company sold a Convertible Promissory Note to the Purchaser with a principal amount of $5,000,000 (the “Note”). The Note will mature on the date that is thirty-six (36) months from the date that the purchase price of the Note is paid to the Company (the “Maturity Date”). The Note bears interest at the rate of 6% per annum, which is payable on Maturity Date. Any outstanding principal and interest on the Note may be converted to the shares of common stock of the Company at the holder’s option at a conversion price of $7.80 per share at any time until the total outstanding balance of the Note is paid. The Note was sold to the Purchaser pursuant to an exemption from registration under Regulation S, promulgated under the Securities Act of 1933, as amended. During the three months ended March 31, 2026, the Company accrued $79,590 as interest expense.

 

Note 13 – Related Party Transactions

 

On September 30, 2011, Diamond Bar leased a showroom in High Point, North Carolina from the Company’s former President, Chief Executive Officer and Chairperson of the Board (resigned during 2025). The lease is renewable and has been renewed each year since 2011. On April 1, 2025, the Company renewed the lease for an additional one year term at a cost of $41,000. During the three months ended March 31, 2026 and 2025, the Company recorded rental amounts of $10,250 and $10,250, respectively, which were included in selling expenses.

 

On January 4, 2018, the Company entered into a sales representative agreement with a consulting firm, which is owned by the former President, Chief Executive Officer and Chairperson of the Board, for sales representative service for a term of two years. On January 4, 2020, the Company renewed the agreement for an additional two years which was amended in July 2020. If not terminated during the first year, the agreement will continue until one party or the other terminates the agreement with 30 days written notice. The Company agreed to compensate the consulting firm via commission at predetermined rates of the relevant sales amount. During the three months ended March 31, 2026 and 2025, the Company recorded $58,108 and $83,436 as commission expense to this consulting firm, respectively.

 

In February 2024, the Company entered into a loan agreement in the aggregate amount of $200,000 with a shareholder of the Company. The loan was in the form of a promissory note dated on February 21, 2024, matures on February 20, 2025, and bears interest at a rate of 8.5% per annum. The proceed of the loan is used for working capital. On February 21, 2025, the Company repaid the loan in the form of shares of common stock. During the three months ended March 31, 2025, the Company recorded $1,932 as interest expense.

 

On April 11, 2024, the Company entered into a loan agreement in the aggregate amount of $160,000 with a shareholder of the Company. The loan was in the form of a promissory note dated on April 11, 2024, matures on April 10, 2025, and bears interest at a rate of 8.5% per annum. The proceed of the loan is used for working capital. On April 10, 2025, the Company extended the loan to April 9, 2026. During the three months ended March 31, 2026 and 2025, the Company accrued $3,779 and $3,565 as interest expense, respectively.

 

On April 11, 2025, the Company entered into a loan agreement in the aggregate amount of $200,000 with a shareholder of the Company. The loan was in the form of a promissory note dated on April 11, 2025, matures on April 10, 2026 and has been paid off by the Company, and bears interest at a rate of 8.5% per annum. The proceed of the loan is used for working capital. During the three months ended March 31, 2026, the Company accrued $4,341 as interest expense.

 

Note 14 – Stockholders’ Equity

 

On May 28, 2021, the Company’s stockholders approved the Company’s 2021 Equity Incentive Plan (the “2021 Plan”) at its annual shareholders’ meeting. The 2021 Plan was approved by the Board of Directors of the Company on April 12, 2021 and has a total of 600,000 shares of the Company’s common stock which may be granted as stock reward to attract and retain personnel, provide additional incentives to employees, directors and consultants and promote the success of the Company’s business. On June 16, 2021, the Company filed Form S-8 to register the 600,000 shares of the Company’s common stock under the 2021 Plan.

 

25

Table of Contents

 

On August 31, 2023, the Company’s stockholders approved the Company’s 2023 Equity Incentive Plan (the “2023 Plan”) at its special shareholders’ meeting. The 2023 Plan was approved by the Board of Directors of the Company on June 28, 2023 and has a total of 800,000 shares of the Company’s common stock which may be granted as stock reward to attract and retain personnel, provide additional incentives to employees, directors and consultants and promote the success of the Company’s business. On December 15, 2023, the Company filed Form S-8 to register the 800,000 shares of the Company’s common stock under the 2023 Plan.

 

On May 31, 2024, the Company’s stockholders approved the Company’s 2024 Equity Incentive Plan (the “2024 Plan”) at its annual shareholders’ meeting. The 2024 Plan was approved by the Board of Directors of the Company on April 19, 2024 and has a total of 3,000,000 shares of the Company’s common stock which may be granted as stock reward to attract and retain personnel, provide additional incentives to employees, directors and consultants and promote the success of the Company’s business.

 

On April 18, 2024, the Company received written notice from the NASDAQ Stock Market (“NASDAQ”) stating that the Company does not meet the requirement of maintaining a minimum of $2,500,000 in stockholders’ equity for continued listing on the NASDAQ Capital Market, as set forth in NASDAQ Listing Rule 5550(b)(1), the Company also does not meet the alternative of market value of listed securities of $35 million under NASDAQ Listing Rule 5550(b)(2) or net income from continuing operations of $500,000 in the most recently completed fiscal year or in two of the last three most recently completed fiscal years under NASDAQ Listing Rule 5550(b)(3), and the Company is no longer in compliance with the NASDAQ Listing Rules.

 

The NASDAQ notification letter provides the Company until June 6, 2024 to submit a plan to regain compliance.

 

The Company submitted its plan of compliance on May 28, 2024 and a supplemental letter to the plan of compliance on June 20, 2024. On June 27, 2024, the Company received a notification letter from NASDAQ Listing Qualification Staff (“Staff”). Based on the review of the letters submitted by the Company, Staff has determined to grant the Company an extension until October 14, 2024 to regain compliance with the Rule and the Company must complete its initiatives and provide evidences for the compliance with the Rule as required by NASDAQ.

 

The Company and Nova Samoa have entered into orders to purchase inventories in total amount of $4,650,000, which were to be paid in 3,321,429 shares (“Transaction”) of common stock of the Company at US$1.40 per share, as disclosed in the Form 8-K filed by the Company with SEC on October 11, 2024 (the “Form 8-K”). The Company believes it has regained compliance with the stockholders’ equity requirement based upon the Transaction.

 

Based on the Form 8-K, staff of NASDAQ (“Staff”) has determined that the Company complies with the Listing Rule 5550(b)(1). However, as noted in its letter dated, June 27, 2024, if the Company fails to evidence compliance upon filing its next periodic report covering the period of the Transaction which is the annual report for the year ended December 31, 2024 (“2024 Form 10-K”), it may be subject to delisting. At that time, Staff will provide written notification to the Company, which may then appeal Staff’s determination to a Hearings Panel. The Company filed its 2024 Form 10-K on March 31, 2025 and has not received any written notification from Nasdaq as of the day of this report.

 

On May 16, 2024, the Company entered into a Securities Purchase Agreement with an investor to sell 200,000 shares of the Company’s common stock at a purchase price of $2.00 per share for an aggregate price of $400,000 (the “Private Placement”). The Private Placement was completed pursuant to the exemption from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended.

 

On July 30, 2024, the Company entered into a Securities Purchase Agreement with the same investor to sell 125,000 shares of the Company’s common stock at a purchase price of $1.60 per share for an aggregate price of $200,000 (the “Private Placement”). The Private Placement was completed pursuant to the exemption from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended.

 

On October 11, 2024, the Company and Nova Samoa entered into five purchase orders (“POs”) to purchase certain furniture products (the “Products”) from Iconic Tech SDN BHD (“Iconic Tech”), Onefull Technologies SDN. BHD. (“Onefull Technologies”), Skyvip SDH BHD (“Skyvip”), United Poles SDH BHD (“United Poles”) and Teclutions System SDN. BHD (“Teclutions”, collectively with Iconic Tech, Onefull Technologies, Skyvip and United Poles as the Sellers). Pursuant to the POs, the Company, Nova Samoa and Sellers agree that (i) Nova Samoa will purchase Background Light Slabs from Iconic Tech for a total of $945,000 (the “Iconic Order Price”); (ii) Nova Samoa will purchase Porcelin Slabs from Onefull Technologies for a total of $925,000 (the “Onefull Order Price”); (iii) Nova Samoa will purchase Transparent Marble Slabs from Skyvip for a total of $900,000 (the “Skyvip Order Price”); (iv) Nova Samoa will purchase Ultrathinstone from United Poles for a total of $940,000 (the “United Order Price”) (v) the Nova Samoa will purchase Light Transmitting Slate Stone from Teclutions for a total of $940,000 (the “Teclutions Order Price”, collectively with Iconic Order Price, Onefull Order Price, Skyvip Order Price and United Order Price as the Order Prices); (vi) the Order Prices shall be paid up to the Sellers in 3,321,429 shares (“Shares”) of common stock of the Company at US$1.40 per share. The Shares were issued pursuant to the exemption from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended.

 

26

Table of Contents

 

On October 25, 2024, the Company entered into a Securities Purchase Agreement (the “Agreement”) with certain purchaser identified on the signature page thereto (the “Purchaser”), pursuant to which the Company agreed to sell to the Purchaser in a private placement 125,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a purchase price of $1.20 per share for an aggregate price of $150,000 (the “Private Placement”). The Private Placement was completed pursuant to the exemption from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended.

 

On January 6, 2025, the Company entered into a Securities Purchase Agreement (the “Agreement”) with certain purchaser identified on the signature page thereto (the “Purchaser”), pursuant to which the Company agreed to sell to the Purchaser in a private placement 250,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a purchase price of $0.60 per share for an aggregate price of $150,000 (the “Private Placement”). The Private Placement was completed pursuant to the exemption from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended.

 

On February 10, 2025, the Company entered into a Securities Purchase Agreement (the “Agreement”) with certain purchaser identified on the signature page thereto (the “Purchaser”), pursuant to which the Company agreed to sell to the Purchaser in a private placement 250,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a purchase price of $0.60 per share for an aggregate price of $150,000 (the “Private Placement”). The Private Placement was completed pursuant to the exemption from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended.

 

On February 20, 2025, the Company entered into a Debt Repayment Agreement (the “Agreement”) with Huge Energy International Limited, a company incorporated in Hong Kong and a creditor of the Company (the “Creditor”), pursuant to which the Company agreed to repay $217,000 debt owed to the Creditor in the form of shares of Common Stock of the Company for an aggregate of 434,000 shares at a price of $0.50 per share (the “Debt Repayment”). The Debt Repayment was completed pursuant to the exemption from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended.

 

On February 26, 2025, the Company and Nova Samoa entered into four purchase orders (“POs”) to purchase certain furniture products (the “Products”) from Flyguy Resources Sdn Bhd (“Flyguy Resources”), Twenty Nine Business Solutions Sdn Bhd. (“Twenty Nine Business”), Chialing Enterprise (“Chialing”) and Macro IT Solutions SDH BHD (“Macro IT Solutions”, collectively with Flyguy Resources, Twenty Nine Business, and Chialing as the “Sellers”). Pursuant to the POs, the Company, Nova Samoa and Sellers agree that (i) Nova Samoa will purchase Transparent Marble Slabs from Flyguy Resources for a total of $810,000 (the “Flyguy Order Price”); (ii) Nova Samoa will purchase Background Light Slabs from Twenty Nine Business for a total of $742,500 (the “Twenty Nine Order Price”); (iii) Nova Samoa will purchase Light Transmitting Slate Stone from Chialing for a total of $825,000 (the “Chialing Order Price”); and (iv) Nova Samoa will purchase Ultrathinstone from Macro IT Solutions for a total of $813,750 (the “Macro Order Price”, collectively with Flyguy Order Price, Twenty Nine Order Price, Chialing Order Price as “Order Prices”); (vi) the Order Prices shall be paid to the Sellers in 4,909,616 shares (“Shares”) of common stock of the Company at US$0.65 per share. The Shares were issued pursuant to the exemption from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended.

 

On March 13, 2025, the Company entered into a Securities Purchase Agreement (the “Agreement”) with certain purchaser identified on the signature page thereto (the “Purchaser”), pursuant to which the Company agreed to sell to the Purchaser in a private placement 500,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a purchase price of $0.40 per share for an aggregate price of $200,000 (the “Private Placement”). The Private Placement was completed pursuant to the exemption from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended.

 

27

Table of Contents

 

On September 4, 2025, the Company, entered into a Securities Purchase Agreement (the “Purchase Agreement”) with purchasers named therein (each, a “Purchaser” and collectively the “Purchasers”), pursuant to which the Company agreed to sell, in a best-efforts public offering, an aggregate of (i) 9,836,054 shares (the “Shares”) of the Company’s common stock, par value $0.001 (“Common Stock”) and (ii) 19,672,108 warrants to purchase 19,672,108 shares of Common Stock (the “Warrants” and such shares of Common Stock issuable upon exercise of the Warrants, the “Warrant Shares”). Each share of Common Stock is being sold together with two Warrants, with each Warrant to purchase one share of Common Stock. The combined purchase price per Share and accompanying Warrants is $0.915.

 

The Warrants are exercisable at an exercise price of $1.098 per share immediately upon issuance, and will expire five years following the date of issuance.

 

On September 4, 2025, the Company closed the public offering of these securities for gross proceeds of approximately $9.0 million (the “Offering”). The net proceeds to the Company from the Offering, after deducting the Placement Agent’s fees and expenses and the Company’s offering expenses is approximately $8.15 million. The Company intends to use the net proceeds for working capital, marketing expenditures, repayment of short-term debt and capital expenditures

 

American Trust Investment Services, Inc. (“ATIS”) acted as the exclusive placement agent for the Offering pursuant to the Placement Agency Agreement, dated September 3, 2025. As compensation for such placement agent services, the Company paid ATIS an aggregate cash fee equal to 7.0% of the gross proceeds received by the Company from the Offering, plus a non-accountable expense allowance equal to 1.0% of the gross proceeds received by the Company, and out-of-pocket expenses of $150,000.

 

The warrants issued in the public offering described above are exercisable for a fixed number of shares, and are classified as equity instruments under ASC 815-40-25-10. The Company accounted for the warrants issued in the public offering based on the fair value method under ASC Topic 505, and the fair value of the warrants was calculated using the Black-Scholes model under the following assumptions: estimated life of 5.5 years, volatility of 124%, risk-free interest rate of 3.65% and dividend yield of 0%. No estimate of forfeitures was made as the Company has a short history of granting options and warrants. The fair value of the warrants issued to investors and placement agent at grant date was $18,308,126.

 

On October 13, 2025, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain purchasers identified on the signature pages thereto (the “Purchasers”), pursuant to which the Company will sell to the Purchasers in a registered direct offering, an aggregate of 3,708,500 shares (the “Shares”) of its common stock, par value $0.001 per share (“Common Stock”) at a purchase price of $3.78 per share, for aggregate gross proceeds to the Company of $14,018,130, before deducting offering expenses payable by the Company.

 

On December 19, 2025, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with two purchasers, an individual and resident of Hong Kong and an individual and resident of China (the “Purchasers”), pursuant to which the Company sold to the Purchasers in a registered direct offering, an aggregate of 1,187,500 shares (the “Shares”) of its common stock, par value $0.001 per share (“Common Stock”) at a purchase price of $4.21 per share, for aggregate gross proceeds to the Company of $4,999,375, before deducting offering expenses payable by the Company. The Shares were offered and sold by the Company pursuant to an effective shelf registration statement on Form S-3 previously filed with the U.S. Securities and Exchange Commission on October 13, 2023 and declared effective on October 23, 2023 (File No. 333-274970).

 

On March 9, 2026, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain purchasers identified on the signature pages thereto (the “Purchasers”), pursuant to which the Company will sell to the Purchasers in a registered direct offering, an aggregate of 8,500,000 shares (the “Shares”) of its common stock, par value $0.001 per share (“Common Stock”) at a purchase price of $4.23 per share, for aggregate gross proceeds to the Company of $35,955,000, before deducting offering expenses payable by the Company.

 

The Shares are being offered and sold by the Company pursuant to an effective shelf registration statement on Form S-3 previously filed with the U.S. Securities and Exchange Commission on October 13, 2023 and declared effective on October 23, 2023 (File No. 333-274970) (the “Registration Statement”).

 

On March 30, 2026, the Company entered into a Securities Purchase Agreement (the “Agreement”) with StratoCore Solutions Ltd., a Malaysian company (the “Purchaser”), pursuant to which the Company agreed to sell to the Purchaser in a private placement 1,958,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a purchase price of $3.575 per share for an aggregate offering price of $6,999,850 (the “Private Placement”). The Private Placement will be completed pursuant to the exemption from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended.

 

28

Table of Contents

 

Shares and Warrants issued through Private Placement

 

On July 23, 2021, the Company conducted a registered direct offering of 222,902 shares of common stock. The shares were offered and sold by the Company pursuant to an effective shelf registration statement on Form S-3, which was filed with the Securities and Exchange Commission (the “SEC”) on October 8, 2020 and subsequently declared effective on October 15, 2020. Additionally, the Company issued to the investors unregistered warrants to purchase up to an aggregate of 222,902 shares of common stock in a concurrent private placement. The combined purchase price for one share of common stock and a warrant to purchase one share of common stock was $14.00. The warrants have an exercise price of $17.50 per share, are exercisable beginning six-months from the date of issuance, and will expire five and a half years from the date of issuance. The offering gross proceeds were $3,120,622 before deducting placement agent’s commissions and other offering costs, and the net proceeds of the offering were approximately $2,760,000. The offering closed on July 27, 2021.

 

In conjunction with this offering, the Company issued warrants to purchase 22,290 shares of common stock at an exercise price of $17.50 per share to the placement agent and its designees. The placement agent warrants are exercisable on the six-month anniversary of the issuance date. The placement agent warrants are exercisable for four and a half years from the initial exercise date. The placement agent warrants have piggy-back registration rights and have a termination date of July 23, 2026.

 

The warrants issued in the private placement described above are exercisable for a fixed number of shares, and are classified as equity instruments under ASC 815-40-25-10. The Company accounted for the warrants issued in the private placement based on the fair value method under ASC Topic 505, and the fair value of the warrants was calculated using the Black-Scholes model under the following assumptions: estimated life of 5.5 years, volatility of 107%, risk-free interest rate of 0.71% and dividend yield of 0%. No estimate of forfeitures was made as the Company has a short history of granting options and warrants. The fair value of the warrants issued to investors and placement agent at grant date was $2,018,597.

 

Warrants

 

The following is a summary of the warrant activity for the three months ended March 31, 2026:

 

   Number of
Warrants
   Average
Exercise Price
   Weighted
Average
Remaining
Contractual
Term in Years
 
             
Outstanding at January 1, 2026   1,494,588   $3.79    4.076 
Exercisable at January 1, 2026   1,494,588   $3.79    4.076 
Granted   -    -    - 
Exercised / surrendered   -    -    -15 
Expired   -    -    - 
Outstanding at March 31, 2026   1,494,588   $3.79    3.826 
Exercisable at March 31, 2026   1,494,588   $3.79    3.826 

 

Shares Issued to Consultants

 

On March 1, 2024, Nova Malaysia entered into a consulting agreement with a consultant for IT system related maintenance and services effective on March 1, 2024 for a one-year term. The Company agreed to grant the consultant 100,000 shares of the Company’s common stock, vesting 25% on March 1, 2024, 25% on June 1, 2024, 25% on September 1, 2024 and 25% on December 1, 2024. The fair value of the 100,000 shares was $163,000, which was calculated based on the stock price of $1.63 per share on March 1, 2024. The shares were granted pursuant to the 2023 Omnibus Long-Term Incentive Plan. During the three months ended March 31, 2026 and 2025, the Company charged $0 and $26,906 to consolidated statements of loss and comprehensive loss as consulting fee, respectively.

 

29

Table of Contents

 

On September 3, 2024, Nova Malaysia entered into a consulting agreement with a consultant for IT system related maintenance and services effective on September 1, 2024 for a one-year term. The Company agreed to grant the consultant 100,000 shares of the Company’s common stock, vesting 25% on September 3, 2024, 25% on December 3, 2024, 25% on March 3, 2024 and 25% on June 3, 2024. The fair value of the 100,000 shares was $142,000, which was calculated based on the stock price of $1.42 per share on September 3, 2024. The shares were granted pursuant to the 2023 Omnibus Long-Term Incentive Plan. During the three months ended March 31, 2026 and 2025, the Company charged $0 and $35,500 to consolidated statements of loss and comprehensive loss as consulting fee, respectively.

 

On September 3, 2024, Nova Malaysia entered into a consulting agreement with a consultant for IT system related maintenance and services effective on September 1, 2024 for a one-year term. The Company agreed to grant the consultant 100,000 shares of the Company’s common stock, vesting 25% on September 3, 2024, 25% on December 3, 2024, 25% on March 3, 2024 and 25% on June 3, 2024. The fair value of the 100,000 shares was $142,000, which was calculated based on the stock price of $1.42 per share on September 3, 2024. The shares were granted pursuant to the 2023 Omnibus Long-Term Incentive Plan. During the three months ended March 31, 2026 and 2025, the Company charged $0 and $35,500 to consolidated statements of loss and comprehensive loss as consulting fee, respectively.

 

On November 7, 2024, the Company entered into a consulting agreement with a consultant for consulting and strategy services effective on November 16, 2024 for a one-year term. The Company agreed to grant the consultant 50,000 shares of the Company’s common stock, vesting 25% on February 15, 2025, 25% on May 15, 2025, 25% on August 15, 2025 and 25% on November 15, 2025. The fair value of the 50,000 shares was $49,000, which was calculated based on the stock price of $0.98 per share on November 16, 2024. The shares were granted pursuant to the 2023 Plan. During the three months ended March 31, 2026 and 2025, the Company charged $0 and $12,250 to consolidated statements of loss and comprehensive loss as consulting expenses, respectively.

 

Shares Issued to Employees

 

On November 7, 2024, the Company extended an employment agreement with the Company’s Corporate Secretary for a term of one year effective from November 14, 2024. The Company agreed to grant an award of 6,000 restricted Stock Units to the officer pursuant to the Company’s 2023 Omnibus Equity Plan. The fair value of these shares was $5,880, which was calculated based on the stock price of $0.98 per share on November 7, 2024, the date the award was determined by the Compensation Committee of the Board of Directors, vesting 25% on November 7, 2024, 25% on March 31, 2025, 25% on June 30, 2025 and 25% on September 30, 2025. During the three months ended March 31, 2026 and 2025, the Company recorded $0 and $1,470 to consolidated statements of loss and comprehensive loss as stock compensation expense, respectively.

 

As of March 31, 2026, unrecognized share-based compensation expense was $0.

 

Note 15 – Geographical Analysis

 

Geographical distribution of sales consisted of the following for the three months ended March 31, 2026 and 2025:

 

   2026   2025 
Geographical Areas          
North America  $1,780,202   $2,617,847 
Hong Kong   -    - 
Other countries   1,519    17,871 
Revenues  $1,781,721   $2,635,718 

 

30

Table of Contents

 

Geographical location of identifiable long-lived assets as of March 31, 2026 and 2025:

 

   2026   2025 
Geographical Areas          
North America  $487,316   $1,118,954 
Asia   -    392,931 
Total  $487,316   $1,511,885 

 

Note 16 – Lease

 

On June 17, 2013, the Company entered into a lease agreement for office, warehouse, storage, and distribution space in the United States with a five year term, commencing on November 1, 2013 and expiring on October 31, 2018. The lease agreement also provided an option to extend the term for an additional six years. On April 23, 2018, the Company extended the lease for another three years with an expiration date of October 31, 2021. On October 15, 2021, the Company extended the lease for another five years with an expiration date of October 31, 2026. The initial monthly rental payment is $42,000 with an annual 3% increase.

 

The Company has entered into several lease agreements for office and warehouse space in Commerce, California and showroom space in Las Vegas, Nevada and High Point, North Carolina (see Note 13) on monthly or annual terms.

 

On July 15, 2019, Nova Malaysia entered into a sublease agreement for warehouse space with a two-year term, expiring on July 14, 2021. The initial monthly rental payment was 20,000 Malaysia Ringgit ($4,232) and was increased to 35,000 Malaysia Ringgit ($7,406) effective August 1, 2020. On July 15, 2021, Nova Malaysia extended the lease for another two years with an expiration date of July 31, 2023. Nova Malaysia did not extend this lease after July 31, 2023.

 

On October 29, 2019, Nova Malaysia entered into a lease agreement for a showroom with a two-year term, commencing on December 1, 2019 and expiring on November 30, 2021. On November 26, 2021, Nova Malaysia extended the lease to November 30, 2022 with an option for renewal for another term of 24 months. On October 4, 2022, Nova Malaysia renewed the lease for two years to November 30, 2024. The monthly rental payment is 9,280 Malaysia Ringgit. Nova Malaysia did not extend the lease agreement after November 30, 2024 and Nova Malaysia leases the showroom on month-to-month basis.

 

On August 20, 2020, Nova Malaysia entered into a sublease agreement for an office and service center with a two-year term, commencing on September 1, 2020 and expiring on August 31, 2022. On July 29, 2022, Nova Malaysia extended the lease for another two years with an expiration date of August 31, 2024. The monthly rental payment is 30,000 Malaysia Ringgit. Nova Malaysia did not extend the lease after August 31, 2024.

 

On August 31, 2022, the Company entered into an auto lease agreement with an unrelated auto dealership with a three-year term. The lease commencement date was August 31, 2022. The required rental payment is $1,902 monthly, with payments due on the 30th day of each month, and expired on July 31, 2025. The Company did not renew the lease.

 

On November 8, 2024, the Company entered into an auto lease agreement with an unrelated auto dealership with a three-year term. The lease commencement date was December 23, 2024. The required rental payment is $1,849 monthly, with payments due on the 23rd day of each month, and expiring on November 23, 2027.

 

On December 9, 2024, Nova Malaysia entered into an agreement for a warehouse with a two-year term, commencing on November 15, 2024 and expiring on November 14, 2026. The lease agreement also provided an option to extend the term for an additional two years. The monthly rental payment is 19,200 Malaysia Ringgit. On July 1, 2025, the Company terminated the lease.

 

On July 1, 2025, the Company, as a sublessor, entered into a warehouse space sublease agreement with an unrelated third party with a three-month term. The sublease commencement date was July 1, 2025. The required rental payment is $26,000 monthly. The sublessee agreed to prepay totaling $78,000 for July, August and September 2025 with security deposit of $50,000 on the commencement day. The sublease expired on September 30, 2025.

 

31

Table of Contents

 

Operating lease expense for the three months ended March 31, 2026 and 2025 was as follows:

 

   2026   2025 
           
Operating lease cost – straight line  $174,413   $193,690 

 

The following is a schedule, by years, of maturities of operating lease liabilities as of March 31, 2026:

 

   Operating Leases 
2026  $419,174 
Thereafter   - 
Total undiscounted cash flows   419,174 
Less: imputed interest   (3,496)
Present value of lease liabilities   415,678 

 

Lease Term and Discount Rate

 

   March 31, 2026 
Weighted-average remaining lease term – years     
Operating leases – USA   0.59 
      
Weighted-average discount rate (%)     
Operating leases – USA   3.36 

 

Supplemental cash flow information related to leases where the Company was the lessee for the three months ended March 31, 2026 and 2025 was as follows:

 

   2026   2025 
           
Operating cash outflows from operating leases  $175,619   $186,413 

 

Finance lease expense for the three months ended March 31, 2026 and 2025 was as follows:

 

   2026   2025 
           
Finance lease cost – straight line  $5,545   $11,251 

 

The following is a schedule, by years, of maturities of finance lease liabilities as of March 31:

 

   Finance Leases 
2026  $16,635 
2027   20,332 
Thereafter   - 
Total undiscounted cash flows   36,967 
Less: imputed interest   (1,556)
Present value of lease liabilities   35,411 
Less: Finance lease liabilities - current   20,858 
Finance lease liabilities - non-current   14,553 

 

32

Table of Contents

 

Lease Term and Discount Rate

 

   March 31,
2026
 
Weighted-average remaining lease term – years     
Finance leases – USA   1.65 
      
Weighted-average discount rate (%)     
Finance leases – USA   5.49 

 

Supplemental cash flow information related to leases where the Company was the lessee for the three months ended March 31, 2026 and 2025 was as follows:

 

   2026   2025 
           
Operating cash outflows from finance leases  $5,545   $11,251 

 

Note 17 – Subsequent Events

 

The Company has evaluated subsequent events through May 14, 2026, the date of the issuance of the consolidated financial statements, and identified the following material subsequent event.

 

On April 1, 2026, the Company incorporated XMax AI Inc. in the State of Nevada. On April 6, 2026, XMax AI Inc. (“XMax AI”) entered into an AI Inference Platform Deployment and Service Agreement (the “Agreement”) with Cloud Alliance Inc. (the “Service Provider”), effective as of April 1, 2026. Pursuant to the Agreement, the Service Provider will develop and deploy an AI inference platform (“Platform”) to the Amazon Web Services (AWS) cloud environment designated by the Company for a total fixed service fee of US$400,000.

 

On April 13, 2026, the Company entered into Securities Purchase Agreements (the “Agreements”) with twenty two non-U.S. person investors, namely Chen Yingjie, Fang Chongyi, Jiang Yan, Ma Ying, Ren Guangfei, Ren Tao, Shen Xiaoyan, Song Rongrong, Tan Kaichang, Tang Min, Wang Haifeng, Wang Jinhua, Wang Li, Wang Zecui, Wei Huifen, Yao Jing, Yu Suying, Zeng Qingyu, Zhang Bingli, Zhang Ciqiang, Zhao Xianxian and Zhao Zheyao (the “Purchasers”), pursuant to which the Company agreed to sell to the Purchasers in a private placement for a total of 462,500 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a purchase price of $6.705 per share for an aggregate offering price of $3,101,062.50 (the “Private Placement”). The Private Placement will be completed pursuant to the exemption from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended.

 

On April 15, 2026, Xmax Beta Holdings Ltd. (the “Xmax Beta”), a company incorporated in the Cayman Islands and an indirectly wholly owned subsidiary of XMax Inc. entered into a Subscription Agreement (the “Agreement”) with Preamble X Capital I, a series of Preamble X Capital LLC, a Delaware Limited Liability Company. Pursuant to the Agreement, Xmax Beta made additional subscription in an aggregate amount of US$5,450,000 (the “Subscription Amount”), which increases Xmax Beta’s interest in Preamble X Capital I to more than 99.9%. Allocations Fund Administration, LLC is the administrative manager of Preamble X Capital I. The applicable management fee percentage for Xmax Beta is 0%. On April 15, 2026, Xmax Beta completed the subscription.

 

33

Table of Contents

 

On April 17, 2026, Preamble X Capital I entered into a Subscription Agreement with a private investment fund (the “Fund”). Pursuant to the Agreement, Preamble X Capital I subscribed for approximately a 3.680% interest in the Fund for an aggregate amount of $5,350,000 (the “Transaction”), which amount the Fund intends to invest and acquire beneficially 258,051 shares of Class A Common Stock of Space Exploration Technologies Corp., a Texas corporation (“SpaceX”). On April 20, 2026, Preamble X Capital I completed the Transaction.

 

On April 22, 2026, XMax AI Inc. (“XMax AI” or the “Party A”), a wholly owned subsidiary of XMax Inc., entered into a Cloud Services Agreement (the “Agreement”) with SuperX AI Technology USA (the “Party B”).

 

Pursuant to the Agreement, Party B shall provide to Party A: (a) cloud computing services - Party B delivers cloud computing resources to Party A utilizing a third party’s cloud infrastructure; (b) API access to large language models and AI models hosted on cloud platforms; and (c) value-added services including cloud architecture design and optimization, technical support and troubleshooting, billing and cost analysis, migration planning, security and compliance advisory, and related technical training. The service fees for the Agreement are US$4,800,000, payable monthly and the model and cloud resource discount rates apply to cumulative consumption up to the discount cap within each consecutive twelve (12) month period commencing from the service activation date. Party A retains full ownership of all data, content and information stored, processed or transmitted through the Services (“Customer Data”). Party B shall access Customer Data only to the extent necessary to perform its obligations and shall not use Customer Data for any other purpose. This Agreement becomes effective upon commencement of services. Unless either Party gives written non-renewal notice at least sixty (60) days before expiry, the term shall automatically renew for one (1) year. This Agreement terminates in the following circumstances, without liability to the other Party (provided that the terminating Party gives written notice): (a) dissolution of either Party (excluding reorganization, renaming or merger); (b) material breach by one Party entitling the other to terminate; (c) force majeure or mutual agreement; or (d) termination required by law. Unless otherwise agreed in this Agreement, neither Party may unilaterally terminate without cause during the term, failing which it shall bear liability for breach. Party A may terminate this Agreement upon thirty (30) days’ prior written notice, and shall pay all fees accrued through the effective date of termination (including used but unbilled amounts). Party B may terminate this Agreement upon thirty (30) days’ prior written notice, refunding any unused prepayments and remaining deposit (if any) within ten (10) days after the effective date of termination.

 

On April 24, 2026, the Company entered into Securities Purchase Agreements (the “Agreements”) with six non-U.S. investors (the “Purchasers”), pursuant to which the Company agreed to sell to the Purchasers in a private placement for a total of 8,550,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a purchase price of $3.64 per share for an aggregate offering price of $31,122,000 (the “Private Placement”). The Private Placement will be completed pursuant to the exemption from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended.

 

CAUTIONARY STATEMENT FOR FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. Words such as “may,” “will,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” the negatives of such terms and other terms of similar meaning typically identify forward-looking statements. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those listed under the heading “Risk Factors” and those listed in our Annual Report on Form 10-K for the year ended December 31, 2025 (the “2025 Form 10K”). The following discussion should be read in conjunction with our Financial Statements and related Notes thereto included elsewhere in this report and in our 2025 Form 10-K. Unless the context otherwise requires, references in this report to “we,” “us,” “XMax” “Nova Lifestyle” or the “Company” refer to XMax Inc. and its subsidiaries.

 

34

Table of Contents

 

Item 2. Managements Discussion and Analysis of Financial Condition and Results of Operations

 

Safe Harbor Declaration

 

The following discussion and analysis are based upon our financial statements as of the dates and for the periods presented in this section. You should read this discussion and analysis in conjunction with the financial statements and notes thereto found in Part I, Item 1 of this Form 10-Q and our consolidated financial statements and notes thereto included in our annual report on Form 10-K for the fiscal year ended December 31, 2025 (the “2025 Form 10-K”). All references to the first quarter and first three months of 2026 and 2025 mean the three-month periods ended March 31, 2026 and 2025. In addition to historical information, the following discussion and other parts of this report contain certain forward-looking information. When used in this discussion, the words, “believes,” “anticipates,” “expects” and similar expressions are intended to identify forward-looking statements. Such statements are subject to certain risks and uncertainties, which could cause actual results to differ materially from projected results, due to a number of risks, uncertainties and factors beyond our control. We do not undertake to publicly update or revise any of these forward-looking statements, even if experience or future changes show that the indicated results or events will not be realized. Furthermore, we cannot guarantee future results, events, levels of activity, performance, or achievements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. Readers also are urged to carefully review and consider our discussions regarding the various factors that affect the company’s business, which are described in this section and elsewhere in this report. For more information, see our discussion of risk factors located at Part I, Item 1A of our 2025 Form 10-K.

 

Overview

 

XMax Inc. (the “Company”), formerly known as Nova LifeStyle, Inc., is a distributor of contemporary styled residential and commercial furniture incorporated into a dynamic marketing and sales platform offering retail as well as online selection and global purchase fulfillment. We monitor popular trends and products to create design elements that are then integrated into our product lines that can be used as both stand-alone or whole-room and home furnishing solutions. Through its network of retailers, e-commerce platforms, stagers and hospitality providers, the Company also sells (through an exclusive third-party manufacturing partner) a managed variety of high quality bedding foundation components. The Company has also expanded its business into the development of artificial intelligence technologies, including AI software and platform-based services to support future growth.

 

The Company’s brand family currently includes XMAX, Nova LifeStyle, Diamond Sofa (www.diamondsofa.com) and Nova Living.

 

Our customers for furniture business principally consist of distributors and retailers with specific geographic territories that deploy middle to high end private label home furnishings which have very little competitive overlap with our specific furnishing products or product lines. We are constantly seeking to integrate new sources of distribution and manufacturing that are properly aligned with our growth strategy. This allows us to continually focus on building both our overall distribution and manufacturing relationships through a deployment of popular, as well as trend-based, furnishing solutions worldwide.

 

Our newly developed AI software and platform-based services are to provide our customers access to XMax’s artificial intelligence models through API-based (Application Programming Interface) services. These services are provided via our recently deployed AI platform, enabling the customer to integrate, distribute, and commercialize these capabilities globally under its own branding. Our platform supports high availability and scalable deployment, enabling customers to efficiently integrate advanced AI capabilities into their commercial applications.

 

We are a U.S. holding company with no material assets in the U.S. other than the ownership interests of our wholly owned subsidiaries through which we market, design and sell residential and commercial furniture and provide AI software and platform-based services. Our subsidiaries include Nova Furniture Limited domiciled in the British Virgin Islands (“Nova Furniture”), Nova Furniture Ltd. domiciled in Samoa (“Nova Samoa”), Diamond Bar Outdoors, Inc. domiciled in California (“Diamond Bar”), Nova Living (M) SDN. BHD. domiciled in Malaysia (“Nova Malaysia”), Nova Living (HK) Group Limited domiciled in Hong Kong (“Nova HK”). We also have a wholly owned subsidiaries Xmax AI Inc. incorporated in Nevada and Xmax Capital Ltd. domiciled in Samoa and its wholly owned subsidiaries Xmax Alpha Holdings Ltd. (the “Xmax Alpha”), Xmax Beta Holdings Ltd., Xmax Delta Holdings Ltd. and Xmax Sigma Holdings Ltd., all domiciled in the Cayman Islands. The Company had three former subsidiaries Bright Swallow International Group Limited domiciled in Hong Kong (“Bright Swallow” or “BSI”) which was sold in January 2020, and Nova Furniture Macao Commercial Offshore Limited domiciled in Macao (“Nova Macao”) which was de-registration and liquidation in January 2021. In February 2022, Nova HK entered a de-registration process and transferred all its assets and business to Nova Malaysia. The process of de-registration and liquidation of Nova HK was completed in February 2023.

 

35

Table of Contents

 

On December 12, 2019, we became the sole shareholder of Nova Living (M) SDN. BHD. (“Nova Malaysia”), a company incorporated on July 26, 2019 under the laws of Malaysia. Nova Malaysia marketed and sold high-end physiotherapeutic jade mats for use in therapy clinics, hospitality, and real estate projects in Malaysia and other regions in Southeast Asia. Due to the negative impact caused by COVID-19, we eventually sold the entire jade mats inventory in liquidation sales in June 2023 and existed from Jade Mats business.

 

On November 5, 2020, we acquired Nova Living (HK) Group Limited (“Nova HK”) at cost of $1,290 which was incorporated in Hong Kong on November 6, 2019. Nova HK took over Nova Macao’s business upon its deregistration, however, it had minimum operations in 2021. In February 2022, Nova HK entered a de-registration process and transferred all its assets and business to Nova Malaysia. The process of de-registration and liquidation of Nova HK was completed in February 2023.

 

Our experience developing and marketing products for international markets has enabled us to develop the scale, logistics, marketing, manufacturing efficiencies and design expertise that serve as the foundation for us to expand aggressively into the highly attractive U.S., Canada, South America, Asia and Middle Easter markets.

 

We do not have access to a revolving credit facility. On May 4, 2020, the Company received loan proceeds in the amount of approximately $139,802 under the Paycheck Protection Program (“PPP”). The PPP, established as part of the Coronavirus Aid, Relief and Economic Security Act (“CARES Act”), provides for loans to qualifying businesses for amounts up to 2.5 times of the average monthly payroll expenses of the qualifying business. On May 5, 2020, Diamond Bar Outdoors Inc. (“Diamond Bar”) was granted a loan from Cathay Bank in the aggregate amount of $176,294, pursuant to the Paycheck Protection Program. On June 19, 2020, Diamond Bar was granted a U.S. Small Business Administration (SBA) loan in the aggregate amount of $150,000, pursuant to the Economic Injury Disaster Loan. During the fiscal year of 2025, the Company completed three private placements for gross proceeds of $500,000, a public offering for proceeds of $9 million, two registered direct offerings for approximately $19 million and a convertible note financing for $5 million. The Company also repaid $217,000 debt with its shares of common stock, $6,503 to director and $3,441 to SBA loan for the year ended December 31, 2025. During the first quarter of 2026, the Company also made one registered direct offering for approximately $36 million and one private placement for approximately $7 million. We currently believe that our financial resources will be adequate to finance our operations in the next 12 months. However, in the event that we do need to raise capital in the future, the instability in the securities markets could adversely affect our ability to raise additional capital.

 

On September 25, 2025, Nova BVI entered into a Subscription Agreement (the “Agreement”) with Preamble Capital, A Series of CGF2021 LLC (the “Fund”), a Delaware Limited Liability Company. Pursuant to the Agreement, Nova BVI subscribes 99.82% interest in the Fund in an amount equal to $5,664,500. (the “Subscription Amount”) and will become a member of the Fund and be bound by the LLC Agreement as a member of the Fund. Sydecar LLC, a Delaware limited liability company, is the administrator of the Fund. The applicable management fee percentage for the Company is 0%. The Fund will use the Subscription Amount to subscribe approximately 6.667% interest of certain fund that holds an aggregate of 353,772 shares of Common Stock of Space Exploration Technologies Corp., a Texas corporation (“SpaceX”), comprising of 121,805 shares of Class A Common Stock and 231,967 shares of Class C Common Stock of Space X.

 

On September 25, 2025, Nova BVI closed its subscription of 99.815% interest in Preamble Capital, A Series of CGF2021 LLC (the “Preamble Capital”), a Delaware Limited Liability Company for $5,664,500.

 

On September 24, 2025, the Company incorporate Xmax Capital Ltd. in Samoa (“Xmax Samoa”). On October 3, 2025, Xmax Samoa incorporated Xmax Alpha Holdings Ltd. in Cayman Islands. On October 14, 2025, Xmax Samoa incorporated Xmax Beta Holdings Ltd. and Xmax Delta Holdings Ltd. in Cayman Islands. On October 15, 2025, Xmax Samoa incorporated Xmax Sigma Holdings Ltd. in Cayman Islands. Xmax Samoa is a holding company with no actual business operations. Xmax Beta Holdings Ltd., Xmax Delta Holdings Ltd. and Xmax Sigma Holdings Ltd. currently do not have any business operations.

 

36

Table of Contents

 

On September 26, 2025, Preamble Capital entered into a Subscription Agreement (the “Subscription Agreement”) with a certain fund that holds an aggregate of 353,772 shares of Common Stock of SpaceX, comprising of 121,805 shares of Class A Common Stock and 231,967 shares of Class C Common Stock of Space X. Pursuant to the Subscription Agreement, Preamble Capital subscribed approximately 6.667% interest of such fund for an amount of $5,660,000 (the “Transaction”). On September 29, 2025, Preamble Capital closed the Transaction.

 

On October 15, 2025, Xmax Alpha entered into a Subscription Agreement (the “Agreement”) with Preamble Capital I, A Series of CGF2021 LLC (the “Fund”), a Delaware Limited Liability Company. Pursuant to the Agreement, Xmax Alpha subscribed 99.82% interest in the Fund in an amount equal to $5,605,000 (the “Subscription Amount”) and has become a member of the Fund and been bound by the LLC Agreement as a member of the Fund. Sydecar LLC, a Delaware limited liability company, is the administrator of the Fund. The applicable management fee percentage for the Company is 0%. October 15, 2025, the Company completed the subscription.

 

On October 16, 2025, the Fund entered into a Subscription Agreement with a certain fund to subscribe certain interest of such fund for an amount of $5,600,000, which will be used by such fund to purchase shares of common stock of SpaceX.

 

On December 2, 2025, Xmax Beta Holdings Ltd. (the “Xmax Beta”) entered into a Subscription Agreement (the “Agreement”) with Preamble X Capital I, a series of Preamble X Capital LLC, a Delaware Limited Liability Company. Pursuant to the Agreement, Xmax Beta subscribed approximately 99.88% interest in Preamble X Capital I in an amount equal to US$8,461,428.80 (the “Subscription Amount”) and has become a member of Preamble X Capital I and been bound by the LLC Agreement as a member of Preamble X Capital I. Allocations Fund Administration, LLC is the administrative manager of Preamble X Capital I. The applicable management fee percentage for Xmax Beta is 0%. On December 2, 2025, Xmax Beta completed the subscription.

 

On December 2, 2025, Preamble X Capital I, a series of Preamble X Capital LLC entered into a Subscription Agreement with a dedicated SPV (the “SPV”) to subscribe 40,106 equity certificates in the SPV for an amount of US$2,999,928.80 (the “Transaction”) and the SPV holds 502,236 equity certificates, and each certificate is entitled to a share of Series B Preferred Stock of xAI and such Series B Preferred Stock of xAI are directly held by a certain fund, as previously disclosed in the Form 8-K filed by the Company with SEC on December 8, 2025, amended on December 10, 2025. On December 16, 2025, Preamble X Capital I closed the Transaction.

 

On February 4, 2026, Xmax Beta entered into a Subscription Agreement (the “Agreement”) with Preamble X Capital I, a series of Preamble X Capital LLC, a Delaware Limited Liability Company. Pursuant to the Agreement, Xmax Beta made additional subscription in an aggregate amount of US$3,048,773.60 (the “Subscription Amount”), which increases Xmax Beta’s interest in Preamble X Capital I to approximately 99.9%. Allocations Fund Administration, LLC is the administrative manager of Preamble X Capital I. The applicable management fee percentage for Xmax Beta is 0%. On February 4, 2026, Xmax Beta completed the subscription.

 

On February 4, 2026, Preamble X Capital I entered into a Subscription Agreement with a dedicated SPV (the “SPV”) to subscribe 34,963 equity certificates in the SPV for an amount of US$3,048,773.60. Each certificate is entitled to a share of Series B Preferred Stock of X.AI Holdings Corp., a Nevada corporation (“xAI”), and such Series B Preferred Stock of xAI is directly held by a certain fund.

 

In March 2026, the Board of Directors of the Company approved a strategic expansion into artificial intelligence (“AI”) while continuing to operate and develop its existing furniture business. The initiative is designed to diversify revenue streams and position the Company for long-term growth amid challenging conditions in the furniture market. Under the new strategy, the Company plans to enter several high-growth AI segments, including AI software and hardware development, cloud and GPU compute infrastructure, AI model access and orchestration, and enterprise-focused AI agent deployment. The Company expects these initiatives to create new technology-driven business lines with scalable commercial potential. To support the expansion, the Company may raise capital for research and development, strategic partnerships, joint ventures, or acquisitions in AI and advanced technology sectors. The Company will continue strengthening its core furniture operations as one of its principal business lines. Pending deployment of capital into specific projects, the Company may also manage its capital through prudent investment strategies designed to enhance overall capital efficiency and support long-term shareholder value.

 

37

Table of Contents

 

On April 1, 2026, the Company incorporated XMax AI Inc. in the State of Nevada. On April 6, 2026, XMax AI Inc. (“XMax AI”) entered into an AI Inference Platform Deployment and Service Agreement (the “Agreement”) with Cloud Alliance Inc. (the “Service Provider”), effective as of April 1, 2026. Pursuant to the Agreement, the Service Provider will develop and deploy an AI inference platform (“Platform”) to the Amazon Web Services (AWS) cloud environment designated by the Company for a total fixed service fee of US$400,000.

 

On April 13, 2026, the Company entered into Securities Purchase Agreements (the “Agreements”) with twenty two non-U.S. person investors, namely Chen Yingjie, Fang Chongyi, Jiang Yan, Ma Ying, Ren Guangfei, Ren Tao, Shen Xiaoyan, Song Rongrong, Tan Kaichang, Tang Min, Wang Haifeng, Wang Jinhua, Wang Li, Wang Zecui, Wei Huifen, Yao Jing, Yu Suying, Zeng Qingyu, Zhang Bingli, Zhang Ciqiang, Zhao Xianxian and Zhao Zheyao (the “Purchasers”), pursuant to which the Company agreed to sell to the Purchasers in a private placement for a total of 462,500 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a purchase price of $6.705 per share for an aggregate offering price of $3,101,062.50 (the “Private Placement”). The Private Placement will be completed pursuant to the exemption from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended.

 

On April 15, 2026, Xmax Beta entered into a Subscription Agreement (the “Agreement”) with Preamble X Capital I, a series of Preamble X Capital LLC, a Delaware Limited Liability Company. Pursuant to the Agreement, Xmax Beta made additional subscription in an aggregate amount of US$5,450,000 (the “Subscription Amount”), which increases Xmax Beta’s interest in Preamble X Capital I to more than 99.9%. Allocations Fund Administration, LLC is the administrative manager of Preamble X Capital I. The applicable management fee percentage for Xmax Beta is 0%. On April 15, 2026, Xmax Beta completed the subscription.

 

On April 17, 2026, Preamble X Capital I entered into a Subscription Agreement with a private investment fund (the “Fund”). Pursuant to the Agreement, Preamble X Capital I subscribed for approximately a 3.680% interest in the Fund for an aggregate amount of $5,350,000 (the “Transaction”), which amount the Fund intends to invest and acquire beneficially 258,051 shares of Class A Common Stock of Space Exploration Technologies Corp., a Texas corporation (“SpaceX”). On April 20, 2026, Preamble X Capital I completed the Transaction.

 

On April 22, 2026, XMax AI Inc. (“XMax AI” or the “Party A”), a wholly owned subsidiary of XMax Inc., entered into a Cloud Services Agreement (the “Agreement”) with SuperX AI Technology USA (the “Party B”). Pursuant to the Agreement, Party B shall provide to Party A: (a) cloud computing services - Party B delivers cloud computing resources to Party A utilizing a third party’s cloud infrastructure; (b) API access to large language models and AI models hosted on cloud platforms; and (c) value-added services including cloud architecture design and optimization, technical support and troubleshooting, billing and cost analysis, migration planning, security and compliance advisory, and related technical training. The service fees for the Agreement are US$4,800,000, payable monthly and the model and cloud resource discount rates apply to cumulative consumption up to the discount cap within each consecutive twelve (12) month period commencing from the service activation date. Party A retains full ownership of all data, content and information stored, processed or transmitted through the Services (“Customer Data”). Party B shall access Customer Data only to the extent necessary to perform its obligations and shall not use Customer Data for any other purpose. This Agreement becomes effective upon commencement of services. Unless either Party gives written non-renewal notice at least sixty (60) days before expiry, the term shall automatically renew for one (1) year. This Agreement terminates in the following circumstances, without liability to the other Party (provided that the terminating Party gives written notice): (a) dissolution of either Party (excluding reorganization, renaming or merger); (b) material breach by one Party entitling the other to terminate; (c) force majeure or mutual agreement; or (d) termination required by law. Unless otherwise agreed in this Agreement, neither Party may unilaterally terminate without cause during the term, failing which it shall bear liability for breach. Party A may terminate this Agreement upon thirty (30) days’ prior written notice, and shall pay all fees accrued through the effective date of termination (including used but unbilled amounts). Party B may terminate this Agreement upon thirty (30) days’ prior written notice, refunding any unused prepayments and remaining deposit (if any) within ten (10) days after the effective date of termination.

 

On April 24, 2026, the Company entered into Securities Purchase Agreements (the “Agreements”) with six non-U.S. investors (the “Purchasers”), pursuant to which the Company agreed to sell to the Purchasers in a private placement for a total of 8,550,000 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a purchase price of $3.64 per share for an aggregate offering price of $31,122,000 (the “Private Placement”). The Private Placement will be completed pursuant to the exemption from registration provided by Regulation S promulgated under the Securities Act of 1933, as amended.

 

38

Table of Contents

 

Principal Factors Affecting Our Financial Performance

 

The core focus of the Company’s furniture business today is entirely centered on our products, identifying a fashion-driven generational shift in the general perception and consumption of furniture, being more aware of actual consumer tastes and how best to fulfil and engage that need, and closely integrating product development alongside marketing results in appealing products that adheres to the scope of our target demographic of decision makers in the design, staging and retail fields. A process that is continually refined upon each release cycle, maintaining a singular, cohesive vision. In short, we have better identified our customers and how to cater to them – in the process gaining greater traction with every product launch considerably more so on an international level than ever previous. In addition, we have been developing AI software and platform-based services to provide our customers access to XMax’s artificial intelligence models through API-based (Application Programming Interface) services. These services are provided via our recently deployed AI platform, enabling the customer to integrate, distribute, and commercialize these capabilities globally under its own branding. Our platform supports high availability and scalable deployment, enabling customers to efficiently integrate advanced AI capabilities into their commercial applications. We believe these new strategies will provide us with significant long-term growth opportunities.

 

Significant factors that we believe could affect our operating results for our furniture business are: (i) prices of our furniture products to our domestic and international retailer and wholesaler customers and their markups to end consumers; (ii) general economic conditions in the U.S., Chinese, and other international markets; and (iii) trade war and tariffs imposed by the United States on products manufactured in China and other Asian countries where we purchase our products; and (iv) high interest rate, inflation and slow- down in real estate market. We believe most of our customers are willing to pay for our high quality and stylish products, timely delivery, and strong production capacity at price levels which we expect will allow us to maintain a relatively high gross profit margin for our products. We do not manufacture our products, but instead we utilize third-party manufacturers. In response to the tariffs imposed by the United States on products manufactured in China, we have been in the process of seeking and shifting a portion of our product manufacturing from third-party manufacturers located in China to third-party manufacturers located in other parts of Asia, such as Vietnam, India and/or Malaysia, countries with lower tariffs. However, due to the quality issue and recent increase of tariff announced by President Trump on products from India and other southeastern Asian countries, we still purchase most of our products from China. Implementation of a relocation of manufacturing (which by necessity includes an assessment of the factory’s ability to deliver the quantity of the product, in accordance with the Company’s specifications, and in accordance with the Company’s quality control requirements) is time-consuming and has a lot of uncertainties such as the increase of the tariff of the products from these countries, and only a small portion of suppliers manufacturing our products has been transitioned from China to Malaysia and India starting in 2020. Most of our manufacturing will continue to be performed in China because the good quality and the intellectual know-how necessary to manufacture certain products is not generally available in other Asian countries. Consumer preference trends favoring high quality and stylish products and lifestyle-based furniture suites should also allow us at least to maintain our gross profit margins. The markets in North America are challenging because such markets are experiencing a slow-down and may be entering a recession due to high interest rate and inflation.

 

Significant factors that we believe could affect our operating results for our AI software and platform-based service are:

 

(i) Customer adoption and retention of our newly developed AI software and platform-based services: our revenue growth depends on our ability to attract new customers to our artificial intelligence software and platform-based services. We measure customer adoption through key indicators such as the number of enterprise customers, annual recurring revenue, net dollar-based retention rates, and platform usage volumes. Customer adoption is influenced by the breadth and quality of our AI models and tools, the competitive landscape, and our ability to demonstrate measurable return on investment for our customers. We expect to continue to invest meaningfully in sales and marketing to drive further adoption, and there can be no assurance that such investments will result in proportionate increases in revenue.

 

(ii) Investment in research and development: our ability to maintain and extend our competitive position depends on our continued investment in research and development, including the development of new AI models, features, and platform capabilities. We have invested, and expect to continue to invest, significant resources in research and development. These investments may increase our operating expenses in the near term and may not yield the anticipated revenue or other benefits on a timely basis, or at all. We believe, however, that continued investment in innovation is essential to our long-term growth strategy.

 

(iii) Managing the costs of cloud computing infrastructure: our AI software and platform-based services require substantial cloud computing infrastructure, including graphics processing units and other specialized hardware, to train, deploy, and scale our AI models. The cost of compute resources represents a significant component of our cost of revenue and operating expenses. Fluctuations in the pricing and availability of cloud computing capacity may materially affect our gross margins and overall profitability. We seek to optimize our infrastructure costs through improved model efficiency, strategic partnerships with cloud service providers, and the negotiation of favorable pricing arrangements. Our ability to manage these costs effectively as we scale our platform will be a key determinant of our financial performance.

 

(iv) Competitive landscape for AI software and platform-based services and evolving regulatory landscape governing the development, deployment, and commercialization of artificial intelligence technologies.

 

Critical Accounting Policies

 

While our significant accounting policies are described more fully in Note 2 to our accompanying unaudited condensed consolidated financial statements, we believe the following accounting policies are the most critical to aid you in fully understanding and evaluating this Management’s Discussion and Analysis.

 

There have been no material changes to our critical accounting policies and estimates as compared to the critical accounting policies and estimates described in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025.

 

Basis of Presentation

 

The accompanying unaudited condensed consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”) for XMax Inc. and its subsidiaries, Diamond Bar, i Design, Nova BVI, Nova Samoa, Nova Malaysia and XMax Capital and its subsidiaries.

 

39

Table of Contents

 

Reverse Split

 

On May 22, 2023, the Company filed a Certificate of Change with the Secretary of State of Nevada with an effective date of May 22, 2023, at which time a 1-for-5 reverse stock split of the Company’s authorized shares of common stock, par value $0.001, accompanied by a corresponding decrease in the Company’s issued and outstanding shares of common stock (the “Reverse Stock Split”), was effected. All references to shares and per share data have been retroactively restated to reflect such split.

 

Amendments to Articles of Incorporation

 

On September 5, 2023, the Company filed the Certificate of Change (the “Amendment”) with the Secretary of State for the State of Nevada to amend its Articles of Incorporation to increase the amount of authorized shares of its common stock, par value $0.001 per share, from 3,000,000 to 250,000,000. The Amendment was approved by the Company’s Board of Directors (the “Board”) on June 28, 2023 and by the shareholders at a special meeting of the Company’s shareholders held on August 31, 2023. The Amendment does not affect the rights of the Company’s shareholders and was effective immediately upon filing.

 

On November 3, 2025, the Company filed a Certificate of Change (the “Share Increase Amendment”) with the Secretary of State for the State of Nevada to amend its Articles of Incorporation to increase the amount of authorized shares of its common stock, par value $0.001 per share, from 250,000,000 shares to 5,000,000,000 shares. The Share Increase Amendment was approved by the Company’s Board of Directors (the “Board”) on September 15, 2025 and by the shareholders at a special meeting of the Company’s shareholders held on October 31, 2025. The Share Increase Amendment does not affect the rights of the Company’s shareholders and was effective immediately upon filing.

 

On November 3, 2025, the Company filed a Certificate of Amendment (the “Name Change Amendment”) with the Secretary of State for the State of Nevada to amend its Articles of Incorporation to change the Company’s name from “Nova LifeStyle, Inc.” to “XMax Inc.” The Name Change Amendment was approved by the Board on September 15, 2025 and by the shareholders at a special meeting of the Company’s shareholders held on October 31, 2025. The Name Change Amendment was effective immediately upon filing.

 

Use of Estimates

 

The preparation of financial statements in conformity with U.S. GAAP requires to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. On an ongoing basis, management reviews these estimates and assumptions using the currently available information. Changes in facts and circumstances may cause the Company to revise its estimates. In accordance with ASC 250, the changes in estimates will be recognized in the same period of changes in facts and circumstances. The Company bases its estimates on past experiences and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Estimates are used when accounting for items and matters including, but not limited to, fair value estimation of investment, the allowance for credit loss, valuation of inventories, the valuation of stock-based compensation, income taxes and unrecognized tax benefits, assumptions used in assessing impairment of long-lived assets and goodwill, and loss contingencies. Actual results could differ from those estimates.

 

Accounts Receivable

 

Since January 1, 2024, the Company adopted Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments-Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”), using the modified retrospective transition method. ASU 2016-13 replaces the existing incurred loss impairment model with an expected loss methodology, which will result in more timely recognition of credit losses. Upon adoption, the Company changed the impairment model to utilize a forward-looking current expected credit losses (CECL) model in place of the incurred loss methodology for financial instruments measured at amortized cost and receivables resulting from the application of ASC 606, including contract assets.

 

The Company maintains an allowance for credit losses and records the allowance for credit losses as an offset to accounts receivable and the estimated credit losses charged to the allowance is classified as “General and administrative expenses” in the unaudited condensed consolidated statements of loss and comprehensive loss. The Company assesses collectability by reviewing accounts receivable on aging schedules because the accounts receivable were primarily consisted of receivables arising from product sales. In determining the amount of the allowance for credit losses, the Company considers historical collectability based on past due status, the age of the balances, current economic conditions, reasonable and supportable forecasts of future economic conditions, and other factors that may affect the Company’s ability to collect from customers. Delinquent account balances are written-off against the allowance for expected credit loss after management has determined that the likelihood of collection is not probable.

 

40

Table of Contents

 

We maintained an allowance for expected credit loss of $379 and $258 as of March 31, 2026 and December 31, 2025, respectively. During the three months ended March 31, 2026 and 2025, expected credit losses provision was $121 and $287, respectively. As of March 31, 2026, we had gross receivable of $2,457,617 of which $2,424,846 was over 90 days past due.

 

Advances to Suppliers

 

Advances to suppliers represent amounts paid to suppliers in advance for goods that are yet to be delivered and from which future economic benefits are expected to flow to the Company within the normal operating cycle. Based on our historical records and in normal circumstances, we generally receive goods within 4 to 6 months from the date the advance payment is made.

 

Income Taxes

 

Income taxes are accounted for using an asset and liability method. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at each period end based on enacted tax laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized.

 

The Company follows ASC Topic 740, which prescribes a more-likely-than-not threshold for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. ASC Topic 740 also provides guidance on recognition of income tax assets and liabilities, classification of current and deferred income tax assets and liabilities, accounting for interest and penalties associated with tax positions, accounting for income taxes in interim periods, and income tax disclosures.

 

Under the provisions of ASC Topic 740, when tax returns are filed, it is highly certain that some positions taken would be sustained upon examination by the taxing authorities, while others are subject to uncertainty about the merits of the position taken or the amount of the position that would be ultimately sustained. The benefit of a tax position is recognized in the financial statements in the period during which, based on all available evidence, management believes it is more likely than not that the position will be sustained upon examination, including the resolution of appeals or litigation processes, if any. Tax positions taken are not offset or aggregated with other positions. Tax positions that meet the more-likely-than-not recognition threshold are measured as the largest amount of tax benefit that is more than 50 percent likely of being realized upon settlement with the applicable taxing authority. The portion of the benefits associated with tax positions taken that exceeds the amount measured as described above is reflected as a liability for unrecognized tax benefits in the accompanying balance sheets along with any associated interest and penalties that would be payable to the taxing authorities upon examination.

 

XMax Inc. (formerly Nova Lifestyle, Inc.) and Diamond Bar are subject to U.S. federal and state income taxes. Nova BVI was incorporated in the BVI, Nova Samoa and Xmax Capital was incorporated in Samoa. Xmax Alpha Holdings Ltd, Xmax Beta Holdings Ltd, Xmax Delta Holdings Ltd and Xmas Sigma Holdings Ltd were incorporated in Caymen Island. There is no income tax for companies domiciled in the BVI, Cayman Islands and Samoa. Accordingly, the Company’s unaudited condensed consolidated financial statements do not present any income tax provisions related to the BVI, Cayman Islands and Samoa tax jurisdictions where Nova BVI, Nova Samoa, Xmax Capital, Xmax Alpha Holdings Ltd, Xmax Beta Holdings Ltd, Xmax Delta Holdings Ltd and Xmax Sigma Holdings Ltd are domiciled. Nova Malaysia is incorporated in Malaysia and ceased business operations. Nova Malaysia completed its de-registration with the Malaysian government in the first quarter of 2026.

 

On July 4, 2025, the One Big Beautiful Bill Act (“OBBBA”) was enacted in the U.S. The OBBBA extends permanently, with modifications, tax provisions enacted as part of the 2017 Tax Cuts and Jobs Act and restores and makes permanent many business provisions, such as full expensing for domestic research and development and capital investments. In addition, the OBBBA makes changes to certain U.S. corporate tax provisions, but many are generally not effective until 2026. The enactment of the OBBBA does not have a material impact on the results from operations for the current period.

 

The Tax Cuts and Jobs Act of 2017 (the “Act”) created new taxes on certain foreign-sourced earnings such as global intangible low-taxed income (“GILTI”) under IRC Section 951A, which is effective for the Company for tax years beginning after January 1, 2018. For tax years beginning after December 31, 2025, the One Big Beautiful Bill Act renamed GILTI as net CFC tested income (“NCTI”) and modified the Section 951A calculation. For the quarter ended March 31, 2026, the Company has calculated its best estimate of the impact of NCTI, if any, in its income tax provision in accordance with applicable tax law and guidance available as of the date of this filing.

 

The Tax Cuts and Jobs Act of 2017 also amended IRC Section 174 to require specified research and experimental expenditures to be capitalized and amortized for tax years beginning after December 31, 2021. The One Big Beautiful Bill Act subsequently restored current expensing for domestic research and experimental expenditures paid or incurred in tax years beginning after December 31, 2024, while foreign research and experimental expenditures remain subject to capitalization and amortization over 15 years. For the three months ended March 31, 2026, the Company expensed current-year U.S. research and experimental expenditures for federal income tax purposes. The Company did not elect to accelerate the deduction of unamortized domestic research and experimental expenditures from prior years and continues to amortize such amounts over the remaining applicable amortization period. Since the Company’s research and experimental expenditures were incurred within the United States and the amount is immaterial, the Company does not anticipate a material impact to its income tax provision.

 

As of March 31, 2026 and December 31, 2025, the accumulated undistributed earnings generated by its foreign subsidiaries were approximately $21.7 million and $21.7 million of which substantially all was previously subject to U.S. tax, the one-time transition tax on foreign unremitted earnings required by the Tax Act, GILTI, or NCTI, as applicable. Those earnings are considered to be permanently reinvested and accordingly, no deferred tax expense is recorded for U.S. federal and state income tax or applicable withholding taxes.

 

As of March 31, 2026, unrecognized tax benefits were approximately $0. The total amount of unrecognized tax benefits that, if recognized, would favorably affect the effective tax rate was $0 as of March 31, 2026. As of March 31, 2025, unrecognized tax benefits were approximately $0. The total amount of unrecognized tax benefits that, if recognized, would favorably affect the effective tax rate was $0 as of March 31, 2025.

 

A reconciliation of unrecognized tax benefits excluding interest and penalties (“Gross UTB”) for the three months ended March 31, 2026 and 2025, is as follows:

 

    Gross UTB 
    2026    2025 
Balance – January 1   -    - 
Foreign exchange adjustment   -    - 
Balance – December 31  $-   $- 

 

41

Table of Contents

 

As of March 31, 2026 and December 31, 2025, the Company had cumulatively accrued approximately $0 and $0 for estimated interest and penalties related to unrecognized tax benefits. The Company recorded interest and penalties related to unrecognized tax benefits as a component of income tax (benefit)/expense, which totaled $0 and $0 for the three months ended March 31, 2026 and 2025, respectively; and $0 and $0 for the three months ended March 31, 2025, and 2024, respectively, related to the Company’s continuing operations. The Company does not anticipate any significant changes to its unrecognized tax benefits within the next 12 months.

 

XMax Inc. (formerly Nova Lifestyle) and Diamond Bar are subject to U.S. federal and state income taxes and tax years 2020-2024 remain open to examination by tax authorities in the U.S.

 

Intangible Assets

 

Intangible assets consist primarily of computer software acquired for internal use. Acquired intangible assets are initially recorded at the acquisition-date fair value. Intangible assets are amortized on a straight-line basis over their estimated useful lives and are carried at cost less accumulated amortization. The estimated useful life of computer software is generally 5 years.

 

Revenue Recognition

 

We recognize revenues when our customer obtains control of promised goods or services, in an amount that reflects the consideration which it expects to receive in exchange for those goods. We recognize revenues following the five step model prescribed under ASU No. 606: (i) identify contract(s) with a customer; (ii) identify the performance obligations in the contract; (iii) determine the transaction price; (iv) allocate the transaction price to the performance obligations in the contract; and (v) recognize revenues when (or as) we satisfy the performance obligation.

 

Revenue from product sales is recognized when the customer obtains control of our product, which typically occurs upon shipment to the customer. Each customer order is being distinct and separately identifiable from other customer orders as a single performance obligation to deliver the ordered product in exchange for consideration. The Company offers credit sales to customers with credit periods range from 30 to 90 days. We expense incremental costs of obtaining a contract as and when incurred if the expected amortization period of the asset that it would have recognized is one year or less or the amount is immaterial.

 

Product revenue reserves, which are classified as a reduction in product revenues, are generally characterized in the following categories: discounts, returns and rebates. These reserves are based on estimates of the amounts earned or to be claimed on the related sales and are classified as reductions of accounts receivable as the amount is payable to our customer.

 

Our sales policy allows for the return of product within the warranty period if the product is defective and the defects are our fault. As alternatives for the product return option, the customers have the option of asking us for a discount for products with quality issues, or of receiving replacement parts from us at no cost. The amount of reserves for return of products, the discount provided to the customers, and cost for the replacement parts were immaterial for the three months ended March 31, 2026 and 2025.

 

The Company considers itself acting as a principal for sales of goods which is evidenced by (i) the Company is primarily responsible for fulfilling the promise to provide the specified goods, (ii) the Company has inventory risk before the specified goods have been transferred to a customer or after transfer of control to the customer, (iii) the Company has discretion in establishing the price for the specified good. Thus, the Company’s’ revenue is recognized at a point in time when a promised good is delivered to a customer.

 

We generally expense sales commissions when incurred because the amortization period would have been one year or less. These costs are recorded within selling expenses on our unaudited consolidated statements of operations.

 

42

Table of Contents

 

Foreign Currency Translation and Transactions

 

The accompanying unaudited consolidated financial statements are presented in United States Dollar (“$” or “USD”), which is also the functional currency of XMax Inc. (formerly Nova LifeStyle, Inc.), XMax Capital, XMax Alpha, XMax Beta, Nova Furniture, Nova Samoa, Diamond Bar, and i Design.

 

The Company’s subsidiary with operations in Malaysia uses its local currency, Malaysian Ringgit (“RM”), as its functional currency. An entity’s functional currency is the currency of the primary economic environment in which it operates, which is normally the currency of the environment in which the entity primarily generates and expends cash. Management’s judgment is essential to determine the functional currency by assessing various indicators, such as cash flows, sales price and market, expenses, financing and inter-company transactions and arrangements.

 

Foreign currency transactions denominated in currencies other than the functional currency are translated into the functional currency using the exchange rates prevailing at the dates of the transactions. Monetary assets and liabilities denominated in foreign currencies at the balance sheet date are re-measured at the applicable rates of exchange in effect at that date. Gains and losses resulting from foreign currency re-measurement are included in the statements of operations.

 

The financial statements are presented in U.S. dollars. Assets and liabilities are translated into U.S. dollars at the current exchange rate in effect at the balance sheet date, and revenues and expenses are translated at the average of the exchange rates in effect during the reporting period. Stockholders’ equity accounts are translated using the historical exchange rates at the date the entry to stockholders’ equity was recorded, except for the change in accumulated deficits during the period, which is translated using the historical exchange rates used to translate each period’s income statement. Differences resulting from translating functional currencies to the reporting currency are recorded in accumulated other comprehensive income in the balance sheets.

 

Translation of amounts from RM into U.S. dollars has been made at the following exchange rates:

 

Balance sheet items, except for equity accounts     
March 31, 2026   - 
December 31, 2025   RM4.06 to 1 
      
Income statement and cash flow items     
For the three months ended March 31, 2026   - 
For the three months ended March 31, 2025   RM4.45 to 1 

 

Segment Reporting

 

An operating segment is a component of the Company that engages in business activities from which it may earn revenue and incur expenses and is identified on the basis of the internal financial reports that are provided to and regularly reviewed by the Company’s chief operating decision maker in order to allocate resources and assess performance of the segment.

 

In accordance with ASC 280, Segment Reporting, operating segments are defined as components of an enterprise about which separate financial information is available that is evaluated regularly by the chief operating decision maker (“CODM”), in deciding how to allocate resources and in assessing performance. The Company’s revenue segments have similar economic characteristics and they are managed as a single business unit. The Company uses the “management approach” in determining reportable operating segments. The management approach considers the internal organization and reporting used by the Company’s chief operating decision maker for making operating decisions and assessing performance as the source for determining the Company’s reportable segments. The Company’s CODM has been identified as the chief executive officer (the “CEO”), who reviews consolidated results when making decisions about allocating resources and assessing performance of the Company. The Company has determined that there is only one reportable operating segment.

 

43

Table of Contents

 

We concluded that we had one reportable segment under ASC 280 because Diamond Bar is a furniture distributor based in California focusing on customers in the US. Each of our subsidiaries is operated under the same senior management of our company, and we view the operations of Diamond Bar as a whole for making business decisions. Our long-lived assets are mainly property, plant and equipment located in the United States.

 

Sales to customers by geographic area are determined by reference to the physical product shipment delivery locations requested by our customers. For example, if the products are delivered to a customer in the U.S., the sales are recorded as generated in the U.S.; if the customer directs us to ship its products to China, the sales are recorded as sold in China.

 

New Accounting Pronouncements

 

Recently Adopted Accounting Standards

 

In March 2025, the FASB issued ASU 2025-02—Liabilities (405): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 122. The amendments in this Update are effective immediately and on a fully retrospective basis to annual periods beginning after December 15, 2024. The Company adopted the ASU in 2025. The adoption did not have a material impact on the financial statements.

 

On July 4, 2025, the U.S. H.R.1, an act to provide for reconciliation pursuant to title II of H. Con. Res. 14. (the “OBBBA”) was enacted. The OBBBA introduces multiple tax law and other legislative changes, including modifications to income tax provisions such as domestic research and development expenses, capital expenditures, and U.S. taxation of international earnings; the repeal or acceleration of the sunset of certain tax credits under the 2022 Inflation Reduction Act and elimination of certain penalties for violations of certain regulatory credit programs. We have recognized the effects of the OBBBA provisions in our financial results to the extent they are applicable to the three months ended March 31, 2026. We will continue to evaluate the impact of these provisions on our 2026 and subsequent consolidated financial statements, including loss of certain regulatory credit sales tied to our products and changes to the costs of our products.

 

In March 2023, the FASB issued ASU 2023-01, Lease (Topic 842): Common Control Arrangements, which clarifies the accounting for leasehold improvements associated with leases between entities under common control (hereinafter referred to as common control lease). ASU 2023-01 requires entities to amortize leasehold improvements associated with common control lease over the useful life to the common control group (regardless of the lease term) as long as the lessee controls the use of the underlying asset through a lease, and to account for any remaining leasehold improvements as a transfer between entities under common control through an adjustment to equity when the lessee no longer controls the underlying asset. This ASU will be effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years. Early adoption is permitted for both interim and annual financial statements that have not yet been made available for issuance. An entity may apply ASU 2023-01 either prospectively or retrospectively. The Company is currently evaluating the impact that the adoption of ASU 2023-01 will have on our unaudited condensed consolidated financial statement presentations and disclosures.

 

ln December 2023, the FASB issued Accounting Standards Update No.2023-09, “Income Taxes (Topic 740): Improvements to Income Tax Disclosures” (“ASU 2023-09”), which modifies the rules on income tax disclosures to require entities to disclose (1) specific categories in the rate reconciliation,(2) the income or loss from continuing operations before income tax expense or benefit (separated between domestic and foreign) and (3)income tax expense or benefit from continuing operations (separated by federal, state and foreign). ASU 2023-09 also requires entities to disclose their income tax payments to international, federal, state and local jurisdictions, among other changes. The guidance is effective for annual period beginning after December 15, 2024. Early adoption is permitted for annual financial statements that have not yet been issued or made available for issuance. ASU 2023-09 should be applied on a prospective basis, but retrospective application is permitted. The Company is currently evaluating the potential impact of adopting this new guidance on its unaudited condensed consolidated financial statements and related disclosures.

 

In July 2025, the FASB issued ASU 2025-05, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets. The amendments provide a practical expedient and, if applicable, an accounting policy election to simplify the measurement of credit losses for certain receivables and contract assets. The amendments are effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted in any interim or annual period in which financial statements have not been issued or made available for issuance. The Company is currently evaluating the impact of this amendment and does not expect that the adoption of this guidance will have a material impact on its financial position, results of operations, or cash flows.

 

44

Table of Contents

 

Recently Issued But Not Yet Adopted Accounting Pronouncements

 

On November 4, 2024, the FASB issued an ASU No. 2024-03, Disaggregation of Income Statement Expenses (“ASU 2024 03”) to improve the disclosures about a public business entity’s expenses and address requests from investors for more detailed information about the types of expenses in commonly presented expense captions (such as cost of sales; selling, general, and administrative expenses; and research and development). The amendments in the ASU require disclosure in the notes to financial statements of specified information about certain costs and expenses. The amendments require that at each interim and annual reporting period an entity: 1. Disclose the amounts of (a) purchases of inventory, (b) employee compensation, (c) depreciation, (d) intangible asset amortization, and (e) depreciation, depletion, and amortization recognized as part of oil- and gas-producing activities (or other amounts of depletion expense) included in each relevant expense caption. A relevant expense caption is an expense caption presented on the face of the income statement within continuing operations that contains any of the expense categories listed in (a)–(e). 2. Include certain amounts that are already required to be disclosed under current generally accepted accounting principles in the same tabular disclosure as the other disaggregation requirements. 3. Disclose a qualitative description of the amounts remaining in relevant expense captions that are not separately disaggregated quantitatively. 4) Disclose the total amount of selling expenses and, in annual reporting periods, an entity’s definition of selling expenses. In January 2025, the FASB issued ASU No. 2025-01, Clarifying the Effective Date (“ASU 2025-01”). The amendments, as clarified by ASU 2025-01, are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027. Early adoption is permitted. The amendments in this ASU should be applied either (1) prospectively to financial statements issued for reporting periods after the effective date of the ASU or (2) retrospectively to any or all prior periods presented in the financial statements. The Company is currently evaluating the impact that the adoption of ASU 2024-03 will have on its consolidated financial statement presentation or disclosures.

 

In January 2025, the FASB issued ASU 2025-01 Income Statement-Reporting Comprehensive Income – Expense Disaggregation Disclosures (Subtopic 220-40). The FASB issued ASU 2024-03 on November 4, 2024-03 states that the amendments are effective for public business entities for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Following the issuance of ASU 2024-03, the FASB was asked to clarify the initial effective date for entities that do not have an annual reporting period that ends on December 31 (referred to as non-calendar year-end entities). Because of how the effective date guidance was written, a non-calendar year-end entity may have concluded that it would be required to initially adopt the disclosure requirements in ASU 2024-03 in an interim reporting period, rather than in annual reporting period. The FASB’s intent in the basis for conclusions of ASU 2024-03 is clear that all public business entities should initially adopt the disclosure requirements in the first annual reporting period beginning after December 15, 2026, and interim reporting periods within annual reporting periods beginning after December 15, 2027.

 

In May 2025, the FASB issued ASU 2025-03, Business Combinations (Topic 805) and Consolidation (Topic 810): Determining the Accounting Acquirer in the Acquirer in the Acquisition of a Variable Interest Entity. The amendments provide guidance on identifying the accounting acquirer in transactions involving a variable interest entity. The amendments are effective for annual reporting periods beginning after December 15, 2026, and interim reporting period within those annual periods. Early adoption is permitted as of the beginning of an interim or annual reporting period. The Company is currently evaluating the impact of this amendment and does not expect that the adoption of this guidance will have a material impact on its financial position, results of operations, or cash flows.

 

In May 2025, the FASB issued ASU 2025-04, Compensation - Stock Compensation (Topic 18) and Revenue from contracts with Customers (Topic 606): Clarifications to Share-Based Consideration Payable to a Customer. The amendments provide guidance on identifying the accounting acquirer in transactions involving a variable interest entity. The amendments clarify the accounting for share-based consideration payable to a customer under Topic 718 and Topic 606. The amendments are effective for annual reporting periods, including interim reporting period within those annual periods, beginning after December 15, 2026. Early adoption is permitted. The Company is currently evaluating the impact of this amendment and does not expect that the adoption of this guidance will have a material impact on its financial position, results of operations, or cash flows.

 

45

Table of Contents

 

In September 2025, the FASB issued ASU No. 2025-06, Intangibles—Goodwill and Other—Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software. The ASU simplifies the capitalization guidance by removing all references to prescriptive and sequential software development stages (referred to as “project stages”) throughout ASC 350-40. The ASU is effective for annual periods beginning after December 15, 2027, and interim periods within those fiscal years. Adoption of this ASU can be applied prospectively for reporting periods after its effective date; or follow a modified transition approach that is based on the status of the respective projects and whether software costs were capitalized before the date of adoption; or retrospectively to any or all prior periods presented in the consolidated financial statements. Early adoption is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.

 

In December 2025, the FASB issued ASU No. 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities. The ASU establishes authoritative guidance in GAAP about accounting for government grants received by business entities, clarifies the appropriate accounting, in an effort to reduce diversity in practice, and increase consistency of application across business entities. The ASU is effective for annual reporting periods beginning after December 15, 2028, and interim reporting periods within those annual reporting periods. Adoption of this ASU can be applied a modified prospective approach, a modified retrospective approach, or a retrospective approach. Early adoption is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.

 

In December 2025, the FASB issued ASU No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. The ASU clarifies interim disclosure requirements and the applicability of Topic 270. The objective of the amendments is to provide further clarity about the current interim disclosure requirements. The ASU is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. Adoption of this ASU can be applied either a prospective or a retrospective approach. Early adoption is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.

 

In December 2025, the FASB issued ASU No. 2025-12, Codification Improvements. The ASU addresses thirty-three items, representing the changes to the Codification that (1) clarify, (2) correct errors, or (3) make minor improvements. Generally, the amendments in this Update are not intended to result in significant changes for most entities. The ASU is effective for interim reporting periods within annual reporting periods beginning after December 15, 2026. The adoption method of this ASU may vary, on an issue-by-issue basis. Early adoption is permitted. We are currently evaluating the provisions of this ASU and do not expect this ASU to have a material impact on our consolidated financial statements.

 

In April 2026, the FASB issued ASU 2026-01—Equity (Topic 505): Initial Measurement of Paid-in-Kind Dividends on Equity-Classified Preferred Stock. The amendments in this Update clarify the initial measurement of paid-in-kind dividends on preferred stock that is classified within equity. The amendments in this Update are effective for all entities for annual reporting periods beginning after December 15, 2026, and interim reporting periods within those annual reporting periods. Early adoption is permitted in any interim or annual reporting period in which financial statements have not yet been issued or made available for issuance. An entity adopting the amendments in an interim reporting period should apply them as of the beginning of the annual reporting period that includes that interim reporting period. The Company is currently evaluating the impact that the adoption of ASU 2026-01 will have on its consolidated financial statement presentation or disclosures.

 

We do not believe that any other recently issued, but not yet effective, authoritative guidance, if currently adopted, would have a material impact on our financial statement presentation or disclosures.

 

Results of Operations

 

Comparison of Three Months Ended March 31, 2026 and 2025

 

The following table sets forth the results of our operations for the three months ended March 31, 2026 and 2025.

 

   Three Months Ended March 31, 
   2026   2025 
   $   % of Sales   $   % of Sales 
Sales  $1,781,721        $2,635,718      
Cost of sales   (899,252)   (50)%   (1,431,484)   (54)%
Gross profit   882,469    50%   1,204,234    46%
Operating expenses   (1,417,322)   (80)%   (1,397,594)   (53)%
Loss from operations   (534,853)   (30)%   (193,360)   (7)%
Other income (expenses), net   726,367   41%   (207,771)   (8)%
Income tax benefit (expense)   -    -%   62,260    2%
Net income (loss)   191,514   11%   (338,871)   (13)%

 

46

Table of Contents

 

Sales

 

Sales for the three months ended March 31, 2026 were $1.78 million, a decrease of 32% from $2.64 million for the same period of 2025. This decrease in sales resulted primarily from 36.92% decrease in sales volume, while partially offset by 7.16% increase in average selling price. Our three largest selling product categories for the three months ended March 31, 2026 were sofa, beds and coffee tables, which accounted for approximately 58%, 11% and 10% of sales, respectively. For the three months ended March 31, 2025, the three largest selling categories were sofas, chairs and beds, which accounted for approximately 55%, 10% and 9% of sales, respectively.

 

The $0.86 million decrease in sales for the three months ended March 31, 2026, compared to the same period of 2025, was mainly due to decreased sales to North America. Sales to North America decreased by 32% to $1.78 million for the three months ended March 31, 2026, compared to $2.62 million for the same period of 2025, such decrease mainly due to decrease in sales volume by 37% from the customers in North America. Sales to other countries decreased by $0.02 million to $1,519 for the three months ended March 31, 2026, from $0.02 million for the same period of 2025, primary due to less sales order received from our customers in other countries.

 

Cost of Sales

 

Cost of sales consists primarily of costs of finished goods and materials purchased from third-party manufacturers. Total cost of sales decreased by 37% to $0.90 million for the three months ended March 31, 2026, compared to $1.43 million for the same period of 2025. Cost of sales as a percentage of sales decreased to 50% for the three months ended March 31, 2026, compared to 54% for the same period of 2025. The decrease in cost of sales in dollar term and in cost of sales as a percentage of sales are a result of selling more products with higher profit margins.

 

Gross Profit

 

Gross profit was $0.88 million for the three months ended March 31, 2026, compared to $1.20 million for the same period of 2025, representing a decrease in gross profit of $0.32 million. Our gross profit margin was 50% for the three months ended March 31, 2026, compared to 46% for the same period of 2025. The decrease in gross profit in dollar term was mainly due to a result of less sales. The increase in gross profit in percentage was mainly due to selling more products with higher profit margin.

 

Operating Expenses

 

Operating expenses consisted of selling, general and administrative expenses, and research and development. Operating expenses were $1.42 million for the three months ended December 31, 2026, compared to $1.40 million for the same period of 2025. Selling expenses increased by 13%, or $0.04 million, to $0.37 million for the three months ended March 31, 2026, from $0.33 million for the same period of 2025, primarily due to increased marketing and advertising expenses. Also, general and administrative expenses decreased by 2%, or $0.02 million, to $1.05 million for the three months ended March 31, 2026, from $1.07 million for the same period of 2025, primarily due to a decrease in accounting and auditing fee of $0.04 million and consulting fee of $0.11 million, while the decrease was partially offset by an increase in legal and professional fee of $0.08 million and travel expense of $0.02 million.

 

Other Income (Expenses), Net

 

Other income, net was $0.73 million for the three months ended March 31, 2026, compared to other expense, net of $0.21 million for the same period of 2025, representing an increase in other income of $0.94 million. The increase in other income was due primarily to an increase in unrealized gain of $0.79 million from the investment in the fund of Preamble.

 

47

Table of Contents

 

Income Tax Benefit (Expense)

 

Income tax benefit (expense) was $0 and $62,260 for the three months ended March 31, 2026 and 2025, respectively. The income tax benefit for the three months ended March 31, 2026 was mainly due to unrealized gain of $0.79 million is non-taxable income for the three months ended March 31, 2026.

 

Net Income (Loss)

 

As a result of the foregoing, our net income was $0.19 million for the three months ended March 31, 2026, compared to $0.34 million of net loss for the same period of 2025.

 

Liquidity and Capital Resources

 

Our principal demands for liquidity are related to our efforts to increase sales and purchase inventory, and for expenditures related to sales distribution and general corporate purposes. We intend to meet our liquidity requirements, including capital expenditures related to purchase of inventories and the expansion of our business, primarily through cash flow provided by operations and collections of accounts receivable.

 

We rely primarily on internally generated cash flow and available working capital to support growth. We may seek additional financing in the form of bank loans or other credit facilities or funds raised through offerings of our equity or debt, if and when we determine such offerings are required. As of March 31, 2026, we do not have any credit facilities. We believe that our current cash and cash equivalents and anticipated cash receipts from sales of products will be sufficient to meet our anticipated working capital requirements and capital expenditures for the next 12 months.

 

We had working capital of $18,187,987 at March 31, 2026, an increase of $8,798,031 from net working capital of $9,389,956 at December 31, 2025. The ratio of current assets to current liabilities was 12.99-to-1 at March 31, 2026.

 

The following is a summary of cash provided by or used in each of the indicated types of activities during the three months ended March 31, 2026 and 2025:

 

   2026   2025 
Cash (used in) provided by:          
Operating activities  $(641,744)  $(322,617)
Investing activities   (8,348,773)   - 
Financing activities   12,193,432    282,133 

 

Net cash used in operating activities was $0.64 million for the three months ended March 31, 2026, a decrease in cash outflow by $0.32 million from $0.32 million of cash used in operating activities for the same period of 2025.

 

The increase in cash outflow was attributable primarily to (i) a decrease in cash inflow of $0.21 million for inventory to $0.50 million cash inflow for the three months ended March 31, 2026, from $0.72 million cash inflow for the same period of 2025, such decrease in cash inflow being mainly due to we purchased less products from our suppliers due to reciprocal tariff took effective in April 2025; (ii) an increase in cash outflow of $0.26 million for other current assets to $0.08 million cash outflow for the three months ended March 31, 2026, from $0.19 million cash inflow for the same period of 2025, such increase in cash outflow being mainly due to we made prepayments to our service providers. The increase in operating cash outflow was partially offset by (i) increase in cash inflow of $0.25 million of accounts payable to cash outflow of $0.20 million for the three months ended March 31, 2026, from the accounts payable of cash outflow of $0.44 million for the same period of 2025, such increase in cash inflow being mainly due to purchase more products on credits; (ii) increase in cash inflow of $0.13 million of contract liabilities to cash inflow of $0.03 million for the three months ended March 31, 2026, from the contract liabilities of cash outflow of $0.10 million for the same period of 2025, such increase in cash inflow being primarily due to received more deposits from our customers; (iii) increase in cash inflow of $0.14 million of accrued liabilities and other payables to cash outflow of $0.45 million for the three months ended March 31, 2026, from the accrued liabilities and other payables of cash outflow of $0.60 million for the same period of 2025, such increase in cash inflow being primarily due to that we delayed payments to our service provides.

 

48

Table of Contents

 

Net cash used in investing activities was $8.35 million for the three months ended March 31, 2026, an increase in cash outflow of $8.35 million from $0 million of cash used in investing activities for the same period of 2025. We incurred cash outflow of $5.30 million to loan to a third party and $3.05 million to invest into the funds of Preamble Capital LLC.

 

Net cash provided by financing activities was $12.20 million for the three months ended March 31, 2026, compared to $0.28 million for the same period of 2025. During the three months ended March 31, 2026, we issued stocks to investors with the net proceeds of $12.20 million. During the three months ended March 31, 2025, we sold one million shares of common stock with the proceeds of $0.50 million for our working capital, while we paid off one of loans from shareholder by issued 434,000 shares of our common stocks which was equivalent in the value of $0.22 million.

 

As of March 31, 2026, we had gross accounts receivable of $2,457,617 of which $32,718 was not yet past due, $53 was less than 90 days past due and $2,424,846 was more than 90 days past due. We had an allowance for expected credit losses of $379. As of May 7, 2026, 0.99% of accounts receivable outstanding as of March 31, 2026 had been collected. As of May 7, 2025, all of our accounts receivable outstanding at December 31, 2025 had been collected.

 

As of March 31, 2026 and December 31, 2025, we had advances to suppliers of $225,604 and $313,924, respectively. These supplier prepayments are made for goods before we actually receive them.

 

For a new product, the normal lead time from new product R&D, prototype, and mass production to delivery of goods from our suppliers to us is approximately six to nine months after we make advance payments to our suppliers. For other products, the typical time is 4-6 months after our advance payment. We will consider the need for a reserve when and if a supplier fails to fulfill our orders within the time frame as stipulated in the purchase contracts.

 

As of May 7, 2026, $225,604 or 100% and $313,924 or 100% of our advances to suppliers outstanding at March 31, 2026 and December 31, 2025 had been delivered to us in the form of purchases of furniture, respectively.

 

Other Long-Term Liabilities

 

As of March 31, 2026 and December 31, 2025, we recorded long-term taxes payable of nil million, consisting of an income tax payable of nil, primarily arising from a one-time transition tax recognized in the fourth quarter of 2017 on our post-1986 foreign unremitted earnings, as ASC 740 specifies that tax positions for which the timing of the ultimate resolution is uncertain should be recognized as long-term liabilities.

 

We elected to pay the one-time transition tax over the eight years commencing April 2018.

 

On November 18, 2025, the Company entered into a Convertible Promissory Note Purchase Agreement (the “Agreement”) with Billiongold Holding Limited, a company incorporated under the law of Hong Kong (the “Purchaser”). Pursuant to the Agreement, the Company sold a Convertible Promissory Note to the Purchaser with a principal amount of $5,000,000 (the “Note”). The Note will mature on the date that is thirty-six (36) months from the date that the purchase price of the Note is paid to the Company (the “Maturity Date”). The Note bears interest at the rate of 6% per annum, which is payable on Maturity Date. Any outstanding principal and interest on the Note may be converted to the shares of common stock of the Company at the holder’s option at a conversion price of $7.80 per share at any time until the total outstanding balance of the Note is paid. The Note was sold to the Purchaser pursuant to an exemption from registration under Regulation S, promulgated under the Securities Act of 1933, as amended.

 

Off-Balance Sheet Arrangements

 

There are no off-balance sheet arrangements between us and any other entity that have, or are reasonably likely to have, a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that is material to shareholders.

 

We have not entered into any other financial guarantees or other commitments to guarantee the payment obligations of any third parties. We have not entered into any derivative contracts that are indexed to our shares and classified as stockholders’ equity or that are not reflected in our consolidated financial statements. Furthermore, we do not have any retained or contingent interest in assets transferred to an unconsolidated entity that serves as credit, liquidity or market risk support to such entity. We do not have any variable interest in any unconsolidated entity that provides financing, liquidity, market risk or credit support to us or engages in leasing, hedging or research and development services with us.

 

49

Table of Contents

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Not required.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

We have evaluated, under the supervision of our Chief Executive Officer (“CEO”) and our Chief Financial Officer (“CFO”), the effectiveness of disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”) as of March 31, 2026. Based on this evaluation, our CEO and CFO concluded that as of the end of the period covered by this report, our disclosure controls and procedures were effective.

 

Disclosure controls and procedures are controls and procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act (a) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms and (b) is accumulated and communicated to management, including our CEO and CFO, as appropriate, to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Our disclosure controls and procedures are designed to provide reasonable assurance of achieving their objectives as described above.

 

Changes in Internal Control over Financial Reporting

 

There were no changes in our internal control over financial reporting (as defined in Rule 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during or subsequent to the period covered by this report that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

50

Table of Contents

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

From time to time we are a party to various litigation matters incidental to the conduct of our business. We are not presently party to any legal proceedings the resolution of which we believe would have a material adverse effect on our business, prospects, financial condition, liquidity, results of operation, cash flows or capital levels.

 

Item 1A. Risk Factors

 

Not Applicable

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

None

 

Item 5. Other Information

 

Insider Trading Arrangements

 

During the three months ended March 31, 2026, none of the Company’s directors or executive officers adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements.

 

Item 6. Exhibits

 

EXHIBIT INDEX

 

Exhibit No.   Document Description
31.1 †   Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2 †   Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1 ‡   Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as signed by the Chief Executive Officer
32.2 ‡   Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, as signed by the Chief Financial Officer
     
101.INS†   Inline XBRL Instance Document
101.SCH†   Inline XBRL Schema Document
101.CAL†   Inline XBRL Calculation Linkbase Document
101.DEF†   Inline XBRL Definition Linkbase Document
101.LAB†   Inline XBRL Label Linkbase Document
101.PRE†   Inline XBRL Presentation Linkbase Document
104†   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

† Filed herewith

‡ Furnished herewith

 

51

Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  XMax Inc.
  (Registrant)
     
Date: May 15, 2026 By: /s/ Xiaohua Lu
   

Xiaohua Lu, Chief Executive Officer

(Principal Executive Officer)

     
Date: May 15, 2026   /s/ Jeffery Chuang
   

Jeffery Chuang

Chief Financial Officer

(Principal Financial Officer and Principal Accounting Officer)

 

52

FAQ

How did XMax Inc. (NVFY) perform financially in Q1 2026?

XMax Inc. reported net income of $191,514 for Q1 2026, compared with a net loss of $338,871 a year earlier. The improvement came mainly from investment gains, while core operations still generated an operating loss.

What were XMax Inc. (NVFY) Q1 2026 revenues and operating results?

Q1 2026 net sales were $1.78 million, down from $2.64 million in Q1 2025. Gross profit was $0.88 million, but the company recorded a loss from operations of $534,853, reflecting higher expenses relative to lower revenue.

How large are XMax Inc. (NVFY) investments in funds tied to SpaceX and xAI?

As of March 31, 2026, XMax reported investment in fund of $26.95 million, up from $23.10 million at December 31, 2025. These level 3 non-marketable investments include indirect interests in SpaceX and xAI-related structures.

What financing activities impacted XMax Inc. (NVFY) in Q1 2026?

During Q1 2026, XMax raised $12.20 million from issuing common stock, offset by modest lease and loan repayments. Net cash provided by financing activities was $12.19 million, significantly strengthening the company’s liquidity position.

What is XMax Inc. (NVFY) balance sheet position as of March 31, 2026?

At March 31, 2026, XMax had total assets of $47.14 million and total liabilities of $6.79 million, including $5.12 million of convertible notes. Stockholders’ equity increased to $40.35 million, reflecting share issuances and the quarterly profit.

How much cash and debt does XMax Inc. (NVFY) have after Q1 2026?

XMax reported cash and cash equivalents of $9.91 million at March 31, 2026, up from $6.71 million at year-end 2025. Total liabilities were $6.79 million, with key items including $5.12 million of convertible notes and lease obligations.